WO2003059431A1 - Microneedle devices and methods of manufacture - Google Patents

Microneedle devices and methods of manufacture Download PDF

Info

Publication number
WO2003059431A1
WO2003059431A1 PCT/US2002/037920 US0237920W WO03059431A1 WO 2003059431 A1 WO2003059431 A1 WO 2003059431A1 US 0237920 W US0237920 W US 0237920W WO 03059431 A1 WO03059431 A1 WO 03059431A1
Authority
WO
WIPO (PCT)
Prior art keywords
substrate
microneedle
cover
major surface
capillary volume
Prior art date
Application number
PCT/US2002/037920
Other languages
French (fr)
Inventor
Patrick R. Fleming
Michael D. Delmore
Luther E. Erickson
Richard H. Ferber
Original Assignee
3M Innovative Properties Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Company filed Critical 3M Innovative Properties Company
Priority to IL16255402A priority Critical patent/IL162554A0/en
Priority to JP2003559591A priority patent/JP4382492B2/en
Priority to DE60224842T priority patent/DE60224842T2/en
Priority to EP02794032A priority patent/EP1465698B1/en
Priority to AU2002359490A priority patent/AU2002359490A1/en
Publication of WO2003059431A1 publication Critical patent/WO2003059431A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14507Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A61B5/1451Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
    • A61B5/14514Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150015Source of blood
    • A61B5/150022Source of blood for capillary blood or interstitial fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150274Manufacture or production processes or steps for blood sampling devices
    • A61B5/150282Manufacture or production processes or steps for blood sampling devices for piercing elements, e.g. blade, lancet, canula, needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150534Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
    • A61B5/150572Pierceable protectors, e.g. shields, caps, sleeves or films, e.g. for hygienic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150534Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
    • A61B5/150694Procedure for removing protection means at the time of piercing
    • A61B5/150717Procedure for removing protection means at the time of piercing manually removed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150969Low-profile devices which resemble patches or plasters, e.g. also allowing collection of blood samples for testing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150977Arrays of piercing elements for simultaneous piercing
    • A61B5/150984Microneedles or microblades
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/157Devices characterised by integrated means for measuring characteristics of blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023Drug applicators using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0046Solid microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0053Methods for producing microneedles

Definitions

  • the present invention relates to the field of microneedle devices and methods of manufacturing the same.
  • microneedles or micro-pins Arrays of relatively small structures, sometimes referred to as microneedles or micro-pins, have been disclosed for use in connection with the delivery and/or removal of therapeutic agents and other substances through the skin and other surfaces.
  • microneedle devices include structures having a capillary or passageway formed through the needle. Because the needles are themselves small, the passageways formed in the needles must be limited in size. As a result, the passageways can be. difficult to manufacture because of their small size and the need for accurate location of the passageways within the needles. Another potential problem of passageways small enough to fit within the microneedles is that the passageways may become easily obstructed or clogged during use.
  • microneedle devices that include fluid passageways that are easier to manufacture and that are resistant to obstruction or clogging during use.
  • This need was answered in part by copending and commonly assigned U.S. Patent Application Serial Number 09/947,195, filed on September 5, 2001 and entitled MICRONEEDLE ARRAYS AND METHODS OF MANUFACTURING THE SAME (Attorney Docket No. 55836US002).
  • the microneedles disclosed in that application include channels formed in their outer surfaces, with the channels extending from the base towards the tip of each microneedle. The channels provide convenient fluid paths in connection with the microneedles.
  • the microneedle arrays disclosed in that application may also include conduit structures formed on the substrate surface to enhance fluid flow across the surface of the substrate from which the microneedles project. Once the microneedles have penetrated the skin, a sample of body fluid may flow through the channels to be collected by the conduit structure towards, for example, some type of sensor.
  • the conduit structures can facilitate fluid transport in connection with the microneedles, improvements may still be possible with regard to transporting fluid quickly and efficiently across the devices to, e.g., sensors, etc.
  • the present invention provides microneedle devices and methods of manufacturing the microneedle devices.
  • the microneedle devices include microneedles protruding from a substrate, with the microneedles piercing a cover placed over the substrate surface from which the microneedles protrude.
  • the cover and the microneedle substrate together define a capillary volume in fluid communication with the base of each microneedle.
  • the capillary volume enhances the movement of fluid towards or away from the microneedles by wicking fluids towards or away from the microneedles.
  • the wicking action may be accomplished by selection of suitable spacing between the substrate and the cover and/or by the selection of materials used for the various components in the devices.
  • coatings may be provided within the capillary volume, e.g., hydrophilic coatings, that may enhance the capillary wicking action within the capillary volume.
  • the capillary volume in the microneedle devices may be provided by simply spacing the cover from the substrate surface, or by including some standoff structure between the cover and the surface of the microneedle substrate that can define a minimum distance between the cover and the substrate.
  • the standoff structure may be formed as a part of the substrate surface, a part of the cover, a part of both the substrate surface and the cover, or by a separate article or articles (e.g., loose fillers) interposed between the substrate and the cover.
  • the capillary volume may (in some embodiments) be defined, at least in part, by conduit structures formed on the surface of the substrate on which the microneedle array is located.
  • the conduit structure may be provided in the form of depressions or grooves in the substrate surface.
  • the conduit structures may be formed by barriers, similar to dikes, that protrude above the substrate surface.
  • the microneedle devices of the present invention may, in some embodiments include one or more sensor elements in fluid communication with the capillary volume, such that fluids traveling through the capillary volume contact the sensor element.
  • the sensor element may be used to sense any of a number of properties and/or compositions in the fluids passing through the capillary volume.
  • the sensor element can be a glucose test element. If, for example, the glucose test element includes glucose oxidaze, the fluid sample passing through the capillary volume may be assessed using electrochemical techniques.
  • the cover, the substrate, or another element may be provided with an electrically conductive circuit pattern to facilitate electrochemical analysis of the fluid sample.
  • the sensor element may undergo an optical change dependent on the properties and/or composition of the fluid passing through the capillary volume. Other alternative sensing techniques will be known to those of skill in the art.
  • the present invention provides a microneedle device including a substrate having a first major surface; at least one microneedle projecting from the first major surface of the substrate, the at least one microneedle having a base proximate the first major surface of the substrate and a tip distal from the base; a cover with a first side facing the first major surface of the substrate and a second side facing away from the substrate, wherein the at least one microneedle penetrates through the first side and the second side of the cover; and a capillary volume located between the first major surface of the substrate and the first side of the cover; wherein the capillary volume contacts at least a portion of the base of the at least one microneedle.
  • the present invention provides a microneedle device including a substrate with a first major surface and a second major surface; at least one microneedle projecting from the first major surface of the substrate, the at least one microneedle including a base proximate the first major surface of the substrate and a tip distal from the base; a cover with a first side facing the first major surface of the substrate and a second side facing away from the substrate, wherein the at least one microneedle penetrates through the first side and the second side of the cover; a capillary volume located between the first major surface of the substrate and the first side of the cover; wherein the capillary volume contacts at least a portion of the base of the at least one microneedle; a backing proximate the second major surface of the substrate, wherein the backing extends past a periphery of the substrate; and a cap attached to the backing around the periphery of the substrate, wherein the first major surface of the substrate faces the cap, and wherein the substrate and the at least
  • the present invention provides a method of manufacturing a microneedle device by providing a substrate having a first major surface and at least one microneedle projecting from the first major surface of the substrate, the at least one microneedle including a base proximate the first major surface of the substrate and a tip distal from the base; providing a cover having a first side facing the first major surface of the substrate; forcing the tip of the at least one microneedle through the cover; and forming a capillary volume located between the first major surface of the substrate and the first side of the cover; wherein the capillary volume contacts at least a portion of the base of the at least one microneedle.
  • FIG. 1 is a perspective view of one microneedle device according to the present invention.
  • FIG. 2 is a cross-sectional view of the microneedle device of FIG. 1, taken along line 2-2 in FIG. 1.
  • FIG. 2A is an enlarged cross-sectional view of a portion of the microneedle device of FIG 2 (indicated by boundary 2A in FIG. 2).
  • FIG. 3 is a plan view of a portion of one side of a cover including a standoff structure that may be used in connection with the microneedle devices of the present invention.
  • FIG. 4 is a cross-sectional view of the cover of FIG. 3, taken along line 4-4 in FIG.
  • FIG. 5 is a plan view of a portion of microneedle substrate surface including standoff structure that may be used in connection with the microneedle devices of the present invention.
  • FIG. 6 is a cross-sectional view of the substrate of FIG. 5, taken along line 6-6 in
  • FIG. 5 (with a cover added to illustrate the function of the standoff structure).
  • FIG. 7 is a cross-sectional view of a portion of another microneedle device according to the present invention.
  • FIG. 8 is a plan view of another microneedle device according to the present invention.
  • FIG. 9 is an exploded cross-sectional view of the microneedle device of FIG. 8, taken along line 9-9 in FIG. 8.
  • FIG. 10 is an enlarged cross-sectional view of a portion of the microneedle device of FIG. 8, taken along line 10-10 in FIG. 8.
  • FIG. 11 is a plan view of a microneedle device including a sensor element and electrically conductive circuit pattern.
  • FIG. 12 is a cross-sectional view of the microneedle device of FIG. 11, taken along line 12-12 in FIG. 11.
  • FIG. 13 is a cross-sectional view of another microneedle device according to the present invention.
  • FIG. 14 is a cross-sectional view of another microneedle device according to the present invention.
  • FIG. 15 is a plan view of another microneedle device according to the present invention.
  • FIG. 16 depicts one portion of one method of manufacturing a microneedle device according to the present invention.
  • the present invention provides microneedle devices that may be useful for a variety of purposes.
  • the microneedle devices may be used to deliver or remove fluids from the point at which they are inserted.
  • the microneedle devices include a capillary volume in contact with the base of each of the microneedles.
  • the microneedle devices of the present invention may be used for a variety of purposes.
  • the microneedle devices may be used to deliver drugs or other pharmacological agents through the skin in a variation on transdermal delivery.
  • the height of the microneedles is preferably sufficient to pass through the stratum corneum and into the epidermis. It is also, however, preferable that the height of the microneedles is not sufficiently large to cause significant pain when inserted at a delivery site.
  • the term "microneedle” (and variations thereof) refers to structures having a height above the surface from which they protrude of about 500 micrometers or less. In some instances, microneedles of the present invention may have a height of about 250 micrometers or less.
  • microneedle devices of the present invention may include only one microneedle on each substrate. Further, although the microneedle devices are all depicted with only one substrate, each device could include multiple substrates, with each substrate including one or more microneedles protruding therefrom. Referring now to FIGS. 1, 2 and 2 A, a portion of one microneedle device 10 is illustrated with microneedles 30 protruding from a surface 22 of a microneedle substrate 20. The microneedles 30 may be arranged in any desired pattern or distributed over the surface 22 randomly. The microneedles 30 may each include a channel 32 formed in the outer surface of the tapered microneedle.
  • the microneedles 30 each include a base 34 proximate the substrate surface 22 and a tip 36 distal from the base 34.
  • the general shape of the microneedles 30 is tapered.
  • the microneedles 30 have a larger base 34 at the substrate surface 22 and extend away from the substrate surface 22, tapering towards a tip 36. It may be preferred, e.g., that the shape of the microneedles used in connection with the present invention be generally conical.
  • Each of the microneedles in the depicted device 10 may also preferably include a channel 32 that extends from the base 34 (or near the base) of the microneedle towards the tip 36 of the microneedle.
  • the channels may typically be formed as a void running along the side of the exterior surface of the microneedle 30.
  • the channel 32 may extend to the tip 36 of the microneedle 30 and, in other embodiments, the channel 32 may terminate before reaching the tip 36.
  • the channels 32 formed in microneedles 30 of the present invention can be distinguished from bores or vias formed in other microneedles because they are open along substantially their entire length, e.g., from the base 34 of the microneedle 30 to the terminus of the channel 32.
  • bores or vias formed in other microneedles are typically closed fluid pathways that have an opening at the tip of the microneedle structure.
  • the bases of the microneedles may be elongated to improve the rigidity and structural integrity of the microneedles.
  • the channels In the microneedles with bases that are elongated along an elongation axis, it may be preferred that the channels extend from one of the opposing ends located along the elongation axis.
  • the microneedles 30 include elongated bases as described in the identified application.
  • the microneedle device 10 includes substrate 20 with major surface 22 from which the microneedles 30 protrude.
  • the substrate 20 may also include a substantially flat opposing major surface 24 on the opposite side of the substrate 20.
  • the microneedle device 10 also includes a cover 40 located over the major surface 22 of substrate 20.
  • the cover 40 includes two major sides 42 and 44, with major side 42 being oriented to face the major surface 22 of the substrate 20.
  • Each of the microneedles 30 preferably pierces through the cover 40, such that the base 34 of each microneedle 30 is located within a volume defined between the major surface 22 of the substrate 20 and the side 42 of the cover 40.
  • the cover 40 be provided in the form of a liquid impermeable film, more preferably a polymeric film.
  • a suitable polymeric film may be, e.g., a simultaneously biaxially oriented polypropylene film (with a thickness of, e.g., about 10 to about 20 micrometers).
  • a cover may be a non-homogeneous structure, e.g., a multilayer construction, a binder containing one or more fillers, or any other suitable design.
  • the thickness of the cover may vary based on the height of the microneedles and their intended use, although covers with a thickness less than the height of the microneedles may be preferred.
  • Thicker covers may, however, be used if, for example, they are compressible to allow for penetration of the delivery site by the microneedles when the cover is compressed. In such a situation, a compressible cover with an uncompressed thickness equal to or greater than the height of the microneedles may be acceptable.
  • the volume thus defined between the substrate surface 22 and the cover 40 is the capillary volume.
  • the spacing or distance s (see FIG. 2 A) between the substrate surface 22 and the side 42 of the cover 40 facing the substrate 20 may be controlled by a variety of techniques. In some instances, the distance or spacing that defines the capillary volume will only be loosely controlled, without the assistance of any structures. In other instances, some of which are discussed below, the spacing s may be controlled by standoff structure located within the capillary volume.
  • the spacing s is selected to provide the desired capillary or wicking action required to transport fluid through the capillary volume, either towards the microneedles 30 or away from the microneedles 30. It is preferred that the distance s be greater than zero at the lower end, in some instances about 10 micrometers or more. At the upper end, it may be preferred that the capillary volume have a distance s that is about 100 micrometers or less, more preferably about 40 micrometers or less.
  • the materials used to form the substrate 20 and/or the cover 40 may also be selected for their hydrophilic properties to facilitate fluid transport through the capillary volume.
  • the surfaces within the capillary volume may be structured to enhance fluid transport through the capillary volume.
  • one or more surfaces within the capillary volume may be provided with a hydrophilic coating to enhance fluid transport.
  • suitable hydrophilic coatings are provided by coating the desired surface or surfaces using a surfactant solution that includes from about 0.05% to about 0.5%, by weight, branched chain sodium dodecylbenzene sulfonate and from about 0.10% to about 0.6%, by weight, ethoxylated acetylenic diol, in a solvent including a 70/30 mix of isopropyl alcohol and water.
  • the microneedles 30 include channels 32 formed along their exterior surfaces, it may be preferred that the channels 32 be in fluid communication with the capillary volume formed between the substrate 20 and the cover 40. Putting the channels 32 in fluid communication with the capillary volume will typically enhance the transport of fluids through the microneedle device 10.
  • channel 32 Although only one type of channel 32 is depicted in FIGS. 1 and 2, it should be understood that any suitable channel structure may be provided in connection with the microneedles of the present invention.
  • the microneedles may be provided without channels if fluid transport along the exterior surface of the microneedles can be provided in the absence of channels.
  • the exterior surfaces of the microneedles may be textured or otherwise treated to improve the ability of fluids to move along the surface of the microneedles. Those treatments may, in some instances, include the hydrophilic coatings described above.
  • FIGS. 3 and 4 the spacing between the substrate and a cover 140 may be controlled by, e.g., standoff structure 146 provided on the cover 140.
  • FIG. 3 depicts one example of a standoff structure that may be useful in connection with the present invention.
  • the standoff structure 146 includes pillars formed such that they protrude from the surface 142 of the cover 140.
  • the pillars may be of substantially the same height as depicted in FIG. 4, or they may be of different heights if so desired.
  • the spacing between the pillars may also vary depending on the specific application of the microneedle device.
  • the standoff structure 146 is in the form of circular cylindrical pillars, it should be understood that the standoff structure may be provided in any suitable shape or combination of shapes, e.g., pyramids, hemispherical protrusions, walls, etc. It may be preferred that the standoff structure 146 be formed integrally with the cover, e.g., as a structured surface molded or otherwise formed in the cover material. Alternatively, the standoff structure may be provided in the form of separate articles attached to the cover (e.g., loosely bonded fillers, microbeads, cube corner elements, etc.).
  • FIGS. 5 and 6 depict another variation in standoff structures that may be used in connection with the present invention with a cover 240 present in FIG.
  • the standoff structure 226 is formed such that it protrudes from the surface 222 of the microneedle substrate 220.
  • the depicted standoff structure 226 is in the form of elongated prisms that may preferably define channels or conduits in which the microneedles 230 are located. In some instances, these elongated standoff structures 226 may provide some directionality to fluid flow through the capillary volume formed between the cover 240 and the substrate 220, with fluid flow being generally controlled along the direction of the elongated standoff structures 226.
  • the standoff structure 226 be formed integrally with the substrate 220, e.g., as a structured surface molded or otherwise formed in the substrate 220.
  • the standoff structure may be provided in the form of separate articles attached to the substrate (e.g., loosely-bonded fillers, prisms, microbeads, cube corner elements, etc.).
  • the standoff structure may not be attached to any surface within the capillary volume and may, instead, take the form of particulates dispersed within the capillary volume.
  • FIG. 7 depicts yet another variation in a microneedle device 310 according to the present invention.
  • the device 310 includes a substrate 320 from which microneedles 330 protrude.
  • the microneedles 330 pierce a cover 340 as described above, with a capillary volume being defined between the substrate 320 and the cover 340.
  • the capillary volume is largely open and unobstructed (with the exception of the microneedle bases and any standoff structure located within the capillary volume).
  • a standoff structure in the form of a porous layer 350 is shown.
  • the porous layer 350 may preferably be largely coextensive with the capillary volume, such that the open volume of the capillary volume is provided by the pores or interstices within the porous layer 350.
  • the porous layer 350 may be provided in separated, discrete locations across the surface of the substrate 320.
  • the porous layer 350 may take a variety of constructions, provided that the movement or passage of fluid therethrough is provided for. Examples of some suitable materials for the porous layer 350 may include papers, treated papers, polymers, woven fibers, such as fabrics, or non-woven materials.
  • wet laid products such as paper, spun-laced non-woven, spun-bonded non-woven, polyurethane open and closed-celled foams, carded web non-woven, blown microfiber non-woven, woven fabrics selected from the group consisting of cotton, cellulose, rayon, acetate, polyester, nylon, polypropylene, polyethylene, urethane, glass, metal, and blends thereof may, in some instances be used.
  • the porous layer 350 alone may function as the cover, with no cover layer 340 present. In such a construction, the thickness of the porous layer 350 above the substrate 320 will define the boundaries of the capillary volume.
  • Such a porous cover may, for example, be compressible to allow for additional penetration of the microneedles 330 at a delivery site if so desired.
  • cover layer 340 in which a separate cover layer 340 is present in addition to a porous layer 350, it may be preferred that the cover layer 340 be provided in the form of a liquid impermeable film, more preferably a polymeric film as discussed above.
  • FIGS. 8 & 9 another construction for a microneedle device is depicted.
  • the microneedle device 410 includes a substrate 420 from which microneedles 430 protrude.
  • the device 410 also includes a cover 440 through which the microneedles 430 protrude when the device 410 is manufactured.
  • the cover 440 and the substrate 420 define a capillary volume as discussed above.
  • the device 410 also includes a backing 460 that may be located proximate the opposing surface of the substrate 420 such that the cover 440 faces one major surface of the substrate 420 and the backing 460 faces the opposing major surface of the substrate 420.
  • the backing may preferably include an adhesive 462 such that the backing can be adhered to the substrate 420.
  • the adhesive 462 may preferably be a pressure sensitive adhesive.
  • a backing in connection with the devices of the present invention, it may be of any suitable construction, including single layer films/foils, multilayer constructions (e.g., poly/foil/poly laminates or multi-layer polymeric film constructions), etc. Examples of some suitable backings may be described in connection with the packaging materials, e.g., U.S. Patent Nos. 5,620,095 (Delmore et al.) and 6,099,682 (Krampe et al.).
  • the cover 440 and the backing 460 may both preferably extend beyond the periphery of the substrate 420 to form an area 466 in which the cover 440 and the backing 460 are directly opposing each other without the substrate 420 located therebetween.
  • the cover 440 and the backing 460 may preferably be attached to each other about the periphery of the substrate 420 such that the substrate 420 is enclosed within the cover 440 and the backing 460.
  • the attachment between the cover 440 and the backing 460 may be accomplished by any suitable technique or techniques.
  • the attachment may be accomplished in the depicted embodiment by the adhesive 462 on the backing 460.
  • the backing may be attached by, e.g., thermal bonds (e.g., heat seal bonds, welding, etc.), clamps, etc. It may be preferred that the attachment between the cover 440 and the backing 460 be a hermetic seal.
  • a sensor element 470 is preferably in fluid communication with the capillary volume defined by the cover 440 and the substrate 420, such that fluids traveling through the capillary volume contact the sensor element 470.
  • the sensor element 470 may be used to sense any of a number of properties and/or compositions in the fluids passing through the capillary volume.
  • the sensor element 470 can be a glucose test element.
  • the fluid sample passing through the capillary volume may be assessed using electrochemical techniques.
  • the cover, the substrate, or another element e.g., the backing
  • the sensor element 470 may be a colorimetric sensor that undergoes an optical change dependent on the properties and/or composition of the fluid passing through the capillary volume.
  • FIG. 10 depicts another feature of the microneedle device 410 in an enlarged cross- sectional view. The additional optional feature is a conduit structure 427 formed into the substrate 420.
  • the conduit structure 427 may be formed as a depression or trench into the substrate 420 as depicted.
  • the conduit structure may be provided as a barrier or barriers provided on the surface of the substrate 420 as discussed in connection with U.S. Patent Application Serial Number 09/947,195, filed on September 5, 2001 and entitled MICRONEEDLE ARRAYS AND METHODS OF MANUFACTURING THE SAME (Attorney Docket No. 55836US002).
  • the microneedle 430 includes a channel formed therein (as discussed above) it may be preferred that any conduit structure 427 be in fluid communication with the channel. At a minimum, however, it may be preferred that the conduit structure 427 extend to a point proximate the base 434 of the microneedle 430.
  • the conduit structure 427 may be used to deliver fluids to the channels in the microneedles or they may be used to remove fluids from the channels of the microneedles. In some situations, the conduit structure 427 may both deliver and remove fluids from microneedle insertion sites.
  • the conduit structure may define all or a portion of the capillary volume formed by the substrate 420 and the cover 440. It may be preferred that the conduit structures 427 lead to the void 428 in which the sensor element 470 is located.
  • microneedle may have a different shape. Although many microneedles may have a uniform slope or wall angle (with respect to, e.g., a z axis normal to the substrate surface 12), microneedles of the present invention may have different wall angles.
  • FIG. 10 shows microneedle 430 that includes a lower section having steeper wall angles with respect to the substrate 420, and an upper section 438 proximate the tip 436 having shallower wall angles.
  • the microneedles used in connection with the present invention may have generally vertical wall angles, i.e., the microneedles may be in the form of pins, with sidewalls that are largely orthogonal to the surface of the substrate from which they protrude.
  • FIGS. 11 & 12 depict another embodiment of a microneedle device 510 according to the present invention.
  • the device 510 includes a sensor element 570 and a plurality of microneedles 530.
  • the device 510 also includes an electrically conductive pattern in the form of an anode and cathode 572 and 574 respectively.
  • the conductive pattern may be provided in any suitable form, e.g., printed or patterned metallization, conductive polymers, etc.
  • the conductive pattern is provided on the cover 540, although it will be understood that the conductive pattern may be located at any suitable location or combinations of locations within the device 510 (e.g., on the backing or substrate).
  • Another microneedle device 610 according to the present invention is depicted in
  • the device 610 includes a substrate 620 with microneedles 630 and a cover 640 that form a capillary volume as described above.
  • the device 610 includes a reservoir volume 681 located on the opposite side of the substrate 620.
  • the reservoir volume 681 may be filled with a fluid including, e.g., a medicament or other pharmacological agent to deliver.
  • the volume 681 is defined by a housing 680 that includes an inner surface 682 facing the substrate 620.
  • the housing 680 (in the depicted embodiment) is attached to the substrate 620 itself on the side opposite the microneedles 630. Alternatively, the housing 680 may be attached to the cover 640 outside of the periphery of the substrate 620.
  • the volume 681 may also include a porous compressible material (e.g., a foam) to assist in holding any fluids or drawing of a vacuum using the device 610 (by compressing the porous material and relying on its tendency to expand, thereby drawing fluids into the volume 681 through void 628).
  • a porous compressible material e.g., a foam
  • the substrate 620 preferably includes one or more voids 628 formed therethrough, such that any fluids contained within the reservoir volume 681 can be communicated to the capillary volume formed between the substrate 620 and the cover 640.
  • the reservoir volume is pressured or compressed (by, e.g., manual pressure)
  • the fluids located within the reservoir volume 681 will preferably tend to flow towards the microneedles 630.
  • the housing 680 be resilient, such that it can substantially recover its shape after compression.
  • Still another optional feature that may be included in the device 610 is an optional membrane 686 covering the void 628 in the substrate 620.
  • the membrane 686 may prevent fluid communication between the reservoir volume 681 and the capillary volume formed between the substrate 620 and the cover 640. In the absence of the membrane 686 or after the membrane 686 is ruptured or otherwise opened, the reservoir volume 681 is in fluid communication with the capillary volume.
  • the membrane 686 is shown as being of a limited size, it may extend to the periphery of the substrate 620 such that it is attached to the housing 680 proximate the periphery of the substrate 620. In such a configuration, the membrane 686 may itself be attached to the substrate 620 by adhesives, thermal bonding, etc. and the reservoir volume 681 may be defined between the membrane 686 and the housing 680.
  • Opening of the membrane 686 may conveniently be attained by compressing the housing 680 such that the pressure within the reservoir volume causes the membrane 686 to rupture. Other techniques of opening the membrane 686 may also be used. Furthermore, other techniques and structures for sealing the void 628 may be used in place of a membrane 686.
  • the sealing adhesive 648 may preferably be a pressure sensitive adhesive, that adheres to skin or another delivery site, such that the device 610 is anchored or attached after the microneedles have penetrated at the delivery site.
  • the sealing adhesive 648 may preferably form a seal about each of the microneedles 630, as well as retain the device 610 in contact with the delivery site. The seal may resist fluid flow and/or allow a vacuum to be drawn at the delivery site. It may be preferred that the sealing adhesive 648 be a skin-compatible adhesive, examples of which are well known.
  • the sealing adhesive 648 may preferably be substantially coextensive with the area occupied by the microneedles 630 such that each of the microneedles 630 is surrounded by the adhesive 648 on the surface of the cover 640.
  • microneedle device includes a substrate 720, microneedles 730, cover 740 and backing 760.
  • the backing 760 may preferably be attached to the cover 740 about the periphery of the substrate 720 by an adhesive 762. Further, the cover 740 and the substrate 720 form a capillary volume as discussed above.
  • the backing 760 extends outside of the substrate 720 and the cover 740 to a peripheral area 792 to which a cap 790 is attached. It may be preferred that the cap 790 and the backing 760 are formed of materials and sealed together by adhesives, thermal bonds, etc. such that the substrate 720 and microneedles 730 are enclosed within a hermetic, moisture-impermeable package used to transport and store the device 710 before use. In such an embodiment, the cap 790 would be removed to expose the microneedles 730 before use. Although the cap 790 is depicted as having a formed shape, it will be understood that it could be formed of flexible, unshaped materials, (e.g., laminates, etc.).
  • a ring of sealing adhesive 748 on the outer surface of the cover 740.
  • the ring of sealing adhesive 748 preferably extends about the periphery of the area occupied by the microneedles 730 and provides sealing and/or attachment functions when the microneedles 730 are inserted into a delivery site as discussed above in connection with FIG. 13 and sealing adhesive 648 depicted therein.
  • FIG. 15 depicts yet another microneedle device 810 according to the present invention.
  • the device includes microneedles 830 that are preferably segregated in one area of the device 810.
  • a sensor element array 870 is located outside of the area occupied by the microneedles 830 and includes a number of sensor elements 870a, 870b and 870c, all of which may be used to detect the same or different properties or compositions of fluids passing through the capillary volume.
  • the capillary volume extends over the device such that fluids transmitted into the capillary volume by the microneedles travels across the device 810 into the area occupied by the sensor elements 870.
  • the sensor elements 870 may, for example, be provided in the form of coatings, rather tan separate articles as depicted above.
  • a ring of sealing adhesive 848 is also depicted in connection with device 810.
  • This ring of sealing adhesive 848 may, for example, be located on a backing that extends beyond the periphery of the substrate on which the microneedles 830 are located (as seen in, e.g., FIG. 14).
  • a cap or liner may then be attached to the adhesive 848 (see, e.g., cap 790 in FIG. 14) to protect it during transport of the device. If a cap is used, it may form a portion of a package in which the device 810 is delivered. Upon removal of the cap or liner, the sealing adhesive 848 is exposed and can be used to attach and/or seal the device 810 to the delivery site.
  • FIG. 16 depicts one method of providing a cover pierced by microneedles in connection with the manufacturing of microneedle devices according to the present invention.
  • the piercing of the cover 940 by the microneedles 930 may be accomplished by any suitable technique or techniques. It may, however, be preferred that piercing of the cover 940 by the microneedles 930 be accomplished by simultaneous delivery of force and ultrasonic energy.
  • the substrate 920 with microneedles 930 may be forced against the cover 940 by an ultrasonic horn 990. It may be preferred that the cover and substrate 920 rest on a resilient material 992 (e.g., silicone rubber having a durometer hardness of approximately 18 on the Shore D scale). As the substrate 920 is forced towards the resilient material 992, ultrasonic energy may assist the microneedles in piercing the cover 940 in a manner that results in the formation of the desired capillary volume as described above.
  • a resilient material 992 e.g., silicone rubber having a durometer
  • piercing of the cover by the microneedles may also be used.
  • it may be desirable to provide heat during the piercing process (alone or in connection with ultrasonic energy). In other instances, it may be sufficient to provide force alone, in some instances an impact force of relatively short duration may be preferred.
  • ultrasonic energy it may be applied through the cover 940 rather than through the substrate 920 as depicted in FIG. 16.
  • microneedles, standoff structure (if any), and conduit structure (if any) may preferably be manufactured integrally with the substrate.
  • the various features may preferably formed as a one piece, completely integral unit.
  • the microneedles, standoff structures, and/or conduit structures may be provided separately from the substrate.
  • the microneedle substrates may be manufactured from a variety of materials. Material selection may be based on a variety of factors including the ability of the material to accurately reproduce the desired pattern; the strength and toughness of the material when formed into the microneedles; the compatibility of the material with, for example, human or animal skin; the compatibility of the materials with any fluids to be delivered or removed by the channels formed in the microneedles, etc. For example, it may be preferred that the microneedle arrays of the present invention be manufactured of one or more metals. Regardless of the materials used for the microneedle arrays of the present invention, it may be preferred that the surfaces of the microneedle array that are likely to come into contact with fluids during use have certain wettability characteristics.
  • these surfaces are hydrophilic, e.g., exhibit a static contact angle for water of less than 90 degrees (possibly less than about 40 degrees), so that the fluid can be spontaneously wicked via capillary pressure.
  • the hydrophilic nature of the surfaces may be provided by selection of materials used to manufacture the entire microneedle array, surface treatments of the entire array or only those portions likely to come into contact with fluids, coatings on the entire array or only those portions likely to come into contact with fluids, etc.
  • Microneedles in the microneedle arrays of the present invention can be solid or porous.
  • porous means having that the microneedles include pores or voids through at least a portion of the structure, wherein those pores or voids are sufficiently large and interconnected to permit at least fluid passage.
  • microneedle devices of the invention may be used in a variety of different manners.
  • One manner of using microneedle devices of the present invention is in methods involving the penetration of skin to deliver medicaments or other substances and/or extract blood or tissue. As discussed above, it may be desired that the height of the microneedles in the microneedle devices be sufficient to penetrate the stratum corneum.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Manufacturing & Machinery (AREA)
  • Optics & Photonics (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Microneedle devices and methods of manufacturing the microneedle devices. The microneedle devices include microneedles protruding from a substrate (20), with the microneedles (30) piercing a cover (40) placed over the substrate surface (22) from which the microneedles protrude. The cover (40) and the microneedle substrate (20) together define a capillary volume in fluid communication with the base (34) of each microneedle (30). One manner of using microneedle arrays of the present invention is in methods involving the penetration of skin to deliver medicaments or other substances and/or extract blood or tissue. Manufacturing methods may include simultaneous application of pressure and ultrasonic energy when piercing the cover with the microneedles.

Description

MICRONEEDLE DEVICES AND METHODS OF MANUFACTURE
The present invention relates to the field of microneedle devices and methods of manufacturing the same.
BACKGROUND
Arrays of relatively small structures, sometimes referred to as microneedles or micro-pins, have been disclosed for use in connection with the delivery and/or removal of therapeutic agents and other substances through the skin and other surfaces.
The vast majority of known microneedle devices include structures having a capillary or passageway formed through the needle. Because the needles are themselves small, the passageways formed in the needles must be limited in size. As a result, the passageways can be. difficult to manufacture because of their small size and the need for accurate location of the passageways within the needles. Another potential problem of passageways small enough to fit within the microneedles is that the passageways may become easily obstructed or clogged during use.
As a result, a need existed for microneedle devices that include fluid passageways that are easier to manufacture and that are resistant to obstruction or clogging during use. This need was answered in part by copending and commonly assigned U.S. Patent Application Serial Number 09/947,195, filed on September 5, 2001 and entitled MICRONEEDLE ARRAYS AND METHODS OF MANUFACTURING THE SAME (Attorney Docket No. 55836US002). The microneedles disclosed in that application include channels formed in their outer surfaces, with the channels extending from the base towards the tip of each microneedle. The channels provide convenient fluid paths in connection with the microneedles. The microneedle arrays disclosed in that application may also include conduit structures formed on the substrate surface to enhance fluid flow across the surface of the substrate from which the microneedles project. Once the microneedles have penetrated the skin, a sample of body fluid may flow through the channels to be collected by the conduit structure towards, for example, some type of sensor. Although the conduit structures can facilitate fluid transport in connection with the microneedles, improvements may still be possible with regard to transporting fluid quickly and efficiently across the devices to, e.g., sensors, etc.
SUMMARY OF THE INVENTION
The present invention provides microneedle devices and methods of manufacturing the microneedle devices. The microneedle devices include microneedles protruding from a substrate, with the microneedles piercing a cover placed over the substrate surface from which the microneedles protrude. The cover and the microneedle substrate together define a capillary volume in fluid communication with the base of each microneedle.
The capillary volume enhances the movement of fluid towards or away from the microneedles by wicking fluids towards or away from the microneedles. The wicking action may be accomplished by selection of suitable spacing between the substrate and the cover and/or by the selection of materials used for the various components in the devices. In some instances, coatings may be provided within the capillary volume, e.g., hydrophilic coatings, that may enhance the capillary wicking action within the capillary volume. The capillary volume in the microneedle devices may be provided by simply spacing the cover from the substrate surface, or by including some standoff structure between the cover and the surface of the microneedle substrate that can define a minimum distance between the cover and the substrate. The standoff structure may be formed as a part of the substrate surface, a part of the cover, a part of both the substrate surface and the cover, or by a separate article or articles (e.g., loose fillers) interposed between the substrate and the cover.
The capillary volume may (in some embodiments) be defined, at least in part, by conduit structures formed on the surface of the substrate on which the microneedle array is located. The conduit structure may be provided in the form of depressions or grooves in the substrate surface. Alternatively, the conduit structures may be formed by barriers, similar to dikes, that protrude above the substrate surface.
The microneedle devices of the present invention may, in some embodiments include one or more sensor elements in fluid communication with the capillary volume, such that fluids traveling through the capillary volume contact the sensor element. The sensor element may be used to sense any of a number of properties and/or compositions in the fluids passing through the capillary volume. In one example, the sensor element can be a glucose test element. If, for example, the glucose test element includes glucose oxidaze, the fluid sample passing through the capillary volume may be assessed using electrochemical techniques. In some constructions, the cover, the substrate, or another element (e.g., a backing) may be provided with an electrically conductive circuit pattern to facilitate electrochemical analysis of the fluid sample. Alternatively, the sensor element may undergo an optical change dependent on the properties and/or composition of the fluid passing through the capillary volume. Other alternative sensing techniques will be known to those of skill in the art.
In one aspect, the present invention provides a microneedle device including a substrate having a first major surface; at least one microneedle projecting from the first major surface of the substrate, the at least one microneedle having a base proximate the first major surface of the substrate and a tip distal from the base; a cover with a first side facing the first major surface of the substrate and a second side facing away from the substrate, wherein the at least one microneedle penetrates through the first side and the second side of the cover; and a capillary volume located between the first major surface of the substrate and the first side of the cover; wherein the capillary volume contacts at least a portion of the base of the at least one microneedle. In another aspect, the present invention provides a microneedle device including a substrate with a first major surface and a second major surface; at least one microneedle projecting from the first major surface of the substrate, the at least one microneedle including a base proximate the first major surface of the substrate and a tip distal from the base; a cover with a first side facing the first major surface of the substrate and a second side facing away from the substrate, wherein the at least one microneedle penetrates through the first side and the second side of the cover; a capillary volume located between the first major surface of the substrate and the first side of the cover; wherein the capillary volume contacts at least a portion of the base of the at least one microneedle; a backing proximate the second major surface of the substrate, wherein the backing extends past a periphery of the substrate; and a cap attached to the backing around the periphery of the substrate, wherein the first major surface of the substrate faces the cap, and wherein the substrate and the at least one microneedle are enclosed between the backing and the cap.
In another aspect, the present invention provides a method of manufacturing a microneedle device by providing a substrate having a first major surface and at least one microneedle projecting from the first major surface of the substrate, the at least one microneedle including a base proximate the first major surface of the substrate and a tip distal from the base; providing a cover having a first side facing the first major surface of the substrate; forcing the tip of the at least one microneedle through the cover; and forming a capillary volume located between the first major surface of the substrate and the first side of the cover; wherein the capillary volume contacts at least a portion of the base of the at least one microneedle.
These and other features and advantages of the invention may be described below in connection with various illustrative embodiments of the invention.
BRIEF DESCRIPTION OF THE FIGURES
FIG. 1 is a perspective view of one microneedle device according to the present invention.
FIG. 2 is a cross-sectional view of the microneedle device of FIG. 1, taken along line 2-2 in FIG. 1. FIG. 2A is an enlarged cross-sectional view of a portion of the microneedle device of FIG 2 (indicated by boundary 2A in FIG. 2).
FIG. 3 is a plan view of a portion of one side of a cover including a standoff structure that may be used in connection with the microneedle devices of the present invention. FIG. 4 is a cross-sectional view of the cover of FIG. 3, taken along line 4-4 in FIG.
3.
FIG. 5 is a plan view of a portion of microneedle substrate surface including standoff structure that may be used in connection with the microneedle devices of the present invention. FIG. 6 is a cross-sectional view of the substrate of FIG. 5, taken along line 6-6 in
FIG. 5 (with a cover added to illustrate the function of the standoff structure). FIG. 7 is a cross-sectional view of a portion of another microneedle device according to the present invention.
FIG. 8 is a plan view of another microneedle device according to the present invention. FIG. 9 is an exploded cross-sectional view of the microneedle device of FIG. 8, taken along line 9-9 in FIG. 8.
FIG. 10 is an enlarged cross-sectional view of a portion of the microneedle device of FIG. 8, taken along line 10-10 in FIG. 8.
FIG. 11 is a plan view of a microneedle device including a sensor element and electrically conductive circuit pattern.
FIG. 12 is a cross-sectional view of the microneedle device of FIG. 11, taken along line 12-12 in FIG. 11.
FIG. 13 is a cross-sectional view of another microneedle device according to the present invention. FIG. 14 is a cross-sectional view of another microneedle device according to the present invention.
FIG. 15 is a plan view of another microneedle device according to the present invention.
FIG. 16 depicts one portion of one method of manufacturing a microneedle device according to the present invention.
DETAILED DESCRIPTION OF THE ILLUSTRATIVE EMBODIMENTS OF THE
INVENTION The present invention provides microneedle devices that may be useful for a variety of purposes. For example, the microneedle devices may be used to deliver or remove fluids from the point at which they are inserted. To accomplish that goal, the microneedle devices include a capillary volume in contact with the base of each of the microneedles.
The microneedle devices of the present invention may be used for a variety of purposes. For example, the microneedle devices may be used to deliver drugs or other pharmacological agents through the skin in a variation on transdermal delivery. Where the microneedle devices are to be used for transdermal drug delivery, the height of the microneedles is preferably sufficient to pass through the stratum corneum and into the epidermis. It is also, however, preferable that the height of the microneedles is not sufficiently large to cause significant pain when inserted at a delivery site. As used in connection with the present invention, the term "microneedle" (and variations thereof) refers to structures having a height above the surface from which they protrude of about 500 micrometers or less. In some instances, microneedles of the present invention may have a height of about 250 micrometers or less.
Although the illustrative microneedle devices described herein all include multiple microneedles, it will be understood that microneedle devices of the present invention may include only one microneedle on each substrate. Further, although the microneedle devices are all depicted with only one substrate, each device could include multiple substrates, with each substrate including one or more microneedles protruding therefrom. Referring now to FIGS. 1, 2 and 2 A, a portion of one microneedle device 10 is illustrated with microneedles 30 protruding from a surface 22 of a microneedle substrate 20. The microneedles 30 may be arranged in any desired pattern or distributed over the surface 22 randomly. The microneedles 30 may each include a channel 32 formed in the outer surface of the tapered microneedle.
The microneedles 30 each include a base 34 proximate the substrate surface 22 and a tip 36 distal from the base 34. The general shape of the microneedles 30 is tapered. For example, the microneedles 30 have a larger base 34 at the substrate surface 22 and extend away from the substrate surface 22, tapering towards a tip 36. It may be preferred, e.g., that the shape of the microneedles used in connection with the present invention be generally conical. Each of the microneedles in the depicted device 10 may also preferably include a channel 32 that extends from the base 34 (or near the base) of the microneedle towards the tip 36 of the microneedle. The channels may typically be formed as a void running along the side of the exterior surface of the microneedle 30. In some embodiments, the channel 32 may extend to the tip 36 of the microneedle 30 and, in other embodiments, the channel 32 may terminate before reaching the tip 36. The channels 32 formed in microneedles 30 of the present invention can be distinguished from bores or vias formed in other microneedles because they are open along substantially their entire length, e.g., from the base 34 of the microneedle 30 to the terminus of the channel 32. In contrast, bores or vias formed in other microneedles are typically closed fluid pathways that have an opening at the tip of the microneedle structure. In some embodiments, the bases of the microneedles may be elongated to improve the rigidity and structural integrity of the microneedles. In the microneedles with bases that are elongated along an elongation axis, it may be preferred that the channels extend from one of the opposing ends located along the elongation axis. These and other variations in channeled microneedles are described in more detail in U.S. Patent Application Serial Number 09/947,195, filed on September 5, 2001 and entitled MICRONEEDLE ARRAYS AND METHODS OF MANUFACTURING THE SAME (Attorney Docket No. 55836US002). It may, for example, be preferred that the microneedles 30 include elongated bases as described in the identified application. Referring to FIGS. 2 and 2 A, the microneedle device 10 includes substrate 20 with major surface 22 from which the microneedles 30 protrude. The substrate 20 may also include a substantially flat opposing major surface 24 on the opposite side of the substrate 20.
The microneedle device 10 also includes a cover 40 located over the major surface 22 of substrate 20. The cover 40 includes two major sides 42 and 44, with major side 42 being oriented to face the major surface 22 of the substrate 20. Each of the microneedles 30 preferably pierces through the cover 40, such that the base 34 of each microneedle 30 is located within a volume defined between the major surface 22 of the substrate 20 and the side 42 of the cover 40. It may be preferred, but not required, that the cover 40 be provided in the form of a liquid impermeable film, more preferably a polymeric film. One example of a suitable polymeric film may be, e.g., a simultaneously biaxially oriented polypropylene film (with a thickness of, e.g., about 10 to about 20 micrometers). Regardless of the material or materials used for the cover, it should be understood that although the cover is depicted as a single-layer homogenous structure, it may be a non-homogeneous structure, e.g., a multilayer construction, a binder containing one or more fillers, or any other suitable design. The thickness of the cover may vary based on the height of the microneedles and their intended use, although covers with a thickness less than the height of the microneedles may be preferred. If the cover is too thick, however, it may interfere with penetration of the delivery site by the microneedles. Thicker covers may, however, be used if, for example, they are compressible to allow for penetration of the delivery site by the microneedles when the cover is compressed. In such a situation, a compressible cover with an uncompressed thickness equal to or greater than the height of the microneedles may be acceptable.
The volume thus defined between the substrate surface 22 and the cover 40 is the capillary volume. The spacing or distance s (see FIG. 2 A) between the substrate surface 22 and the side 42 of the cover 40 facing the substrate 20 may be controlled by a variety of techniques. In some instances, the distance or spacing that defines the capillary volume will only be loosely controlled, without the assistance of any structures. In other instances, some of which are discussed below, the spacing s may be controlled by standoff structure located within the capillary volume.
The spacing s is selected to provide the desired capillary or wicking action required to transport fluid through the capillary volume, either towards the microneedles 30 or away from the microneedles 30. It is preferred that the distance s be greater than zero at the lower end, in some instances about 10 micrometers or more. At the upper end, it may be preferred that the capillary volume have a distance s that is about 100 micrometers or less, more preferably about 40 micrometers or less.
In addition to control over the spacing s to facilitate fluid transport through the capillary volume, the materials used to form the substrate 20 and/or the cover 40 may also be selected for their hydrophilic properties to facilitate fluid transport through the capillary volume. Alternatively, or in addition to materials, the surfaces within the capillary volume may be structured to enhance fluid transport through the capillary volume.
In another alternative, one or more surfaces within the capillary volume may be provided with a hydrophilic coating to enhance fluid transport. Examples of suitable hydrophilic coatings are provided by coating the desired surface or surfaces using a surfactant solution that includes from about 0.05% to about 0.5%, by weight, branched chain sodium dodecylbenzene sulfonate and from about 0.10% to about 0.6%, by weight, ethoxylated acetylenic diol, in a solvent including a 70/30 mix of isopropyl alcohol and water.
Referring again to FIG. 2A, if the microneedles 30 include channels 32 formed along their exterior surfaces, it may be preferred that the channels 32 be in fluid communication with the capillary volume formed between the substrate 20 and the cover 40. Putting the channels 32 in fluid communication with the capillary volume will typically enhance the transport of fluids through the microneedle device 10.
Although only one type of channel 32 is depicted in FIGS. 1 and 2, it should be understood that any suitable channel structure may be provided in connection with the microneedles of the present invention. Further, the microneedles may be provided without channels if fluid transport along the exterior surface of the microneedles can be provided in the absence of channels. For example, the exterior surfaces of the microneedles may be textured or otherwise treated to improve the ability of fluids to move along the surface of the microneedles. Those treatments may, in some instances, include the hydrophilic coatings described above.
Turning to FIGS. 3 and 4, the spacing between the substrate and a cover 140 may be controlled by, e.g., standoff structure 146 provided on the cover 140. FIG. 3 depicts one example of a standoff structure that may be useful in connection with the present invention. The standoff structure 146 includes pillars formed such that they protrude from the surface 142 of the cover 140. The pillars may be of substantially the same height as depicted in FIG. 4, or they may be of different heights if so desired. The spacing between the pillars may also vary depending on the specific application of the microneedle device. Although the depicted standoff structure 146 is in the form of circular cylindrical pillars, it should be understood that the standoff structure may be provided in any suitable shape or combination of shapes, e.g., pyramids, hemispherical protrusions, walls, etc. It may be preferred that the standoff structure 146 be formed integrally with the cover, e.g., as a structured surface molded or otherwise formed in the cover material. Alternatively, the standoff structure may be provided in the form of separate articles attached to the cover (e.g., loosely bonded fillers, microbeads, cube corner elements, etc.). FIGS. 5 and 6 depict another variation in standoff structures that may be used in connection with the present invention with a cover 240 present in FIG. 6 to illustrate the function of the standoff structure 226 in spacing the cover 240 from the surface 222. The standoff structure 226 is formed such that it protrudes from the surface 222 of the microneedle substrate 220. The depicted standoff structure 226 is in the form of elongated prisms that may preferably define channels or conduits in which the microneedles 230 are located. In some instances, these elongated standoff structures 226 may provide some directionality to fluid flow through the capillary volume formed between the cover 240 and the substrate 220, with fluid flow being generally controlled along the direction of the elongated standoff structures 226.
It may be preferred that the standoff structure 226 be formed integrally with the substrate 220, e.g., as a structured surface molded or otherwise formed in the substrate 220. Alternatively, the standoff structure may be provided in the form of separate articles attached to the substrate (e.g., loosely-bonded fillers, prisms, microbeads, cube corner elements, etc.).
It should be understood that in some instances the standoff structure may not be attached to any surface within the capillary volume and may, instead, take the form of particulates dispersed within the capillary volume.
FIG. 7 depicts yet another variation in a microneedle device 310 according to the present invention. The device 310 includes a substrate 320 from which microneedles 330 protrude. The microneedles 330 pierce a cover 340 as described above, with a capillary volume being defined between the substrate 320 and the cover 340. In the embodiments described above, the capillary volume is largely open and unobstructed (with the exception of the microneedle bases and any standoff structure located within the capillary volume). In the embodiment depicted in FIG. 7, however, a standoff structure in the form of a porous layer 350 is shown. The porous layer 350 may preferably be largely coextensive with the capillary volume, such that the open volume of the capillary volume is provided by the pores or interstices within the porous layer 350. Alternatively, the porous layer 350 may be provided in separated, discrete locations across the surface of the substrate 320. The porous layer 350 may take a variety of constructions, provided that the movement or passage of fluid therethrough is provided for. Examples of some suitable materials for the porous layer 350 may include papers, treated papers, polymers, woven fibers, such as fabrics, or non-woven materials. For example, wet laid products such as paper, spun-laced non-woven, spun-bonded non-woven, polyurethane open and closed-celled foams, carded web non-woven, blown microfiber non-woven, woven fabrics selected from the group consisting of cotton, cellulose, rayon, acetate, polyester, nylon, polypropylene, polyethylene, urethane, glass, metal, and blends thereof may, in some instances be used. In some constructions, the porous layer 350 alone may function as the cover, with no cover layer 340 present. In such a construction, the thickness of the porous layer 350 above the substrate 320 will define the boundaries of the capillary volume. Such a porous cover may, for example, be compressible to allow for additional penetration of the microneedles 330 at a delivery site if so desired.
In those constructions, however, in which a separate cover layer 340 is present in addition to a porous layer 350, it may be preferred that the cover layer 340 be provided in the form of a liquid impermeable film, more preferably a polymeric film as discussed above. Turning to FIGS. 8 & 9, another construction for a microneedle device is depicted.
The microneedle device 410 includes a substrate 420 from which microneedles 430 protrude. The device 410 also includes a cover 440 through which the microneedles 430 protrude when the device 410 is manufactured. The cover 440 and the substrate 420 define a capillary volume as discussed above. The device 410 also includes a backing 460 that may be located proximate the opposing surface of the substrate 420 such that the cover 440 faces one major surface of the substrate 420 and the backing 460 faces the opposing major surface of the substrate 420. The backing may preferably include an adhesive 462 such that the backing can be adhered to the substrate 420. The adhesive 462 may preferably be a pressure sensitive adhesive.
If a backing is used in connection with the devices of the present invention, it may be of any suitable construction, including single layer films/foils, multilayer constructions (e.g., poly/foil/poly laminates or multi-layer polymeric film constructions), etc. Examples of some suitable backings may be described in connection with the packaging materials, e.g., U.S. Patent Nos. 5,620,095 (Delmore et al.) and 6,099,682 (Krampe et al.). The cover 440 and the backing 460 may both preferably extend beyond the periphery of the substrate 420 to form an area 466 in which the cover 440 and the backing 460 are directly opposing each other without the substrate 420 located therebetween. The cover 440 and the backing 460 may preferably be attached to each other about the periphery of the substrate 420 such that the substrate 420 is enclosed within the cover 440 and the backing 460.
The attachment between the cover 440 and the backing 460 may be accomplished by any suitable technique or techniques. For example, the attachment may be accomplished in the depicted embodiment by the adhesive 462 on the backing 460. In other devices, the backing may be attached by, e.g., thermal bonds (e.g., heat seal bonds, welding, etc.), clamps, etc. It may be preferred that the attachment between the cover 440 and the backing 460 be a hermetic seal.
Also depicted in connection with FIGS. 8 & 9 is the inclusion of a sensor element 470 as a part of the microneedle device 410. The sensor element 470 is preferably in fluid communication with the capillary volume defined by the cover 440 and the substrate 420, such that fluids traveling through the capillary volume contact the sensor element 470. Although only one sensor element 470 is depicted in connection with the device 410, it will be understood that devices according to the present invention may include more than one sensor element. Further, the sensor elements may be the same or different. The sensor element 470 may be used to sense any of a number of properties and/or compositions in the fluids passing through the capillary volume. In one example, the sensor element 470 can be a glucose test element. If, for example, the glucose test element includes glucose oxidaze, the fluid sample passing through the capillary volume may be assessed using electrochemical techniques. In some constructions, the cover, the substrate, or another element (e.g., the backing) may be provided with an electrically conductive circuit pattern to facilitate electrochemical analysis of the fluid sample. Alternatively, the sensor element 470 may be a colorimetric sensor that undergoes an optical change dependent on the properties and/or composition of the fluid passing through the capillary volume. Other alternative sensing techniques will be known to those of skill in the art. FIG. 10 depicts another feature of the microneedle device 410 in an enlarged cross- sectional view. The additional optional feature is a conduit structure 427 formed into the substrate 420. The conduit structure 427 may be formed as a depression or trench into the substrate 420 as depicted. Alternatively, the conduit structure may be provided as a barrier or barriers provided on the surface of the substrate 420 as discussed in connection with U.S. Patent Application Serial Number 09/947,195, filed on September 5, 2001 and entitled MICRONEEDLE ARRAYS AND METHODS OF MANUFACTURING THE SAME (Attorney Docket No. 55836US002).
If the microneedle 430 includes a channel formed therein (as discussed above) it may be preferred that any conduit structure 427 be in fluid communication with the channel. At a minimum, however, it may be preferred that the conduit structure 427 extend to a point proximate the base 434 of the microneedle 430. The conduit structure 427 may be used to deliver fluids to the channels in the microneedles or they may be used to remove fluids from the channels of the microneedles. In some situations, the conduit structure 427 may both deliver and remove fluids from microneedle insertion sites. In some embodiments, the conduit structure may define all or a portion of the capillary volume formed by the substrate 420 and the cover 440. It may be preferred that the conduit structures 427 lead to the void 428 in which the sensor element 470 is located.
Another feature illustrated in FIG. 10 is that the microneedle may have a different shape. Although many microneedles may have a uniform slope or wall angle (with respect to, e.g., a z axis normal to the substrate surface 12), microneedles of the present invention may have different wall angles. For example, FIG. 10 shows microneedle 430 that includes a lower section having steeper wall angles with respect to the substrate 420, and an upper section 438 proximate the tip 436 having shallower wall angles.
In further microneedle shape variations, the microneedles used in connection with the present invention may have generally vertical wall angles, i.e., the microneedles may be in the form of pins, with sidewalls that are largely orthogonal to the surface of the substrate from which they protrude.
Further, although the microneedles and the substrate surfaces of the depicted embodiments are shown with relatively smooth surfaces, the various features of the microneedle devices may have surfaces that are not smooth, e.g., the surfaces may be roughened, structured, etc. to enhance fluid flow over the surface. FIGS. 11 & 12 depict another embodiment of a microneedle device 510 according to the present invention. The device 510 includes a sensor element 570 and a plurality of microneedles 530. The device 510 also includes an electrically conductive pattern in the form of an anode and cathode 572 and 574 respectively. The conductive pattern may be provided in any suitable form, e.g., printed or patterned metallization, conductive polymers, etc. In the depicted embodiment, the conductive pattern is provided on the cover 540, although it will be understood that the conductive pattern may be located at any suitable location or combinations of locations within the device 510 (e.g., on the backing or substrate). Another microneedle device 610 according to the present invention is depicted in
FIG. 13. The device 610 includes a substrate 620 with microneedles 630 and a cover 640 that form a capillary volume as described above. In addition, the device 610 includes a reservoir volume 681 located on the opposite side of the substrate 620. The reservoir volume 681 may be filled with a fluid including, e.g., a medicament or other pharmacological agent to deliver. The volume 681 is defined by a housing 680 that includes an inner surface 682 facing the substrate 620. The housing 680 (in the depicted embodiment) is attached to the substrate 620 itself on the side opposite the microneedles 630. Alternatively, the housing 680 may be attached to the cover 640 outside of the periphery of the substrate 620. The volume 681 may also include a porous compressible material (e.g., a foam) to assist in holding any fluids or drawing of a vacuum using the device 610 (by compressing the porous material and relying on its tendency to expand, thereby drawing fluids into the volume 681 through void 628).
The substrate 620 preferably includes one or more voids 628 formed therethrough, such that any fluids contained within the reservoir volume 681 can be communicated to the capillary volume formed between the substrate 620 and the cover 640. When the reservoir volume is pressured or compressed (by, e.g., manual pressure), the fluids located within the reservoir volume 681 will preferably tend to flow towards the microneedles 630. If the microneedles 630 are, for example, located within the skin of a patient, the fluids can be delivered to those insertion sites. It may be preferred that the housing 680 be resilient, such that it can substantially recover its shape after compression. Still another optional feature that may be included in the device 610 is an optional membrane 686 covering the void 628 in the substrate 620. The membrane 686 may prevent fluid communication between the reservoir volume 681 and the capillary volume formed between the substrate 620 and the cover 640. In the absence of the membrane 686 or after the membrane 686 is ruptured or otherwise opened, the reservoir volume 681 is in fluid communication with the capillary volume. Although the membrane 686 is shown as being of a limited size, it may extend to the periphery of the substrate 620 such that it is attached to the housing 680 proximate the periphery of the substrate 620. In such a configuration, the membrane 686 may itself be attached to the substrate 620 by adhesives, thermal bonding, etc. and the reservoir volume 681 may be defined between the membrane 686 and the housing 680.
Opening of the membrane 686 may conveniently be attained by compressing the housing 680 such that the pressure within the reservoir volume causes the membrane 686 to rupture. Other techniques of opening the membrane 686 may also be used. Furthermore, other techniques and structures for sealing the void 628 may be used in place of a membrane 686.
Another optional feature depicted in FIG. 13 is the inclusion of a layer of sealing adhesive 648 on the outer surface of the cover 640. The sealing adhesive 648 may preferably be a pressure sensitive adhesive, that adheres to skin or another delivery site, such that the device 610 is anchored or attached after the microneedles have penetrated at the delivery site. In addition, the sealing adhesive 648 may preferably form a seal about each of the microneedles 630, as well as retain the device 610 in contact with the delivery site. The seal may resist fluid flow and/or allow a vacuum to be drawn at the delivery site. It may be preferred that the sealing adhesive 648 be a skin-compatible adhesive, examples of which are well known. In the depicted device 610, the sealing adhesive 648 may preferably be substantially coextensive with the area occupied by the microneedles 630 such that each of the microneedles 630 is surrounded by the adhesive 648 on the surface of the cover 640.
Another alternative microneedle device is depicted in connection with FIG. 14, and includes a substrate 720, microneedles 730, cover 740 and backing 760. The backing 760 may preferably be attached to the cover 740 about the periphery of the substrate 720 by an adhesive 762. Further, the cover 740 and the substrate 720 form a capillary volume as discussed above.
In the depicted embodiment, the backing 760 extends outside of the substrate 720 and the cover 740 to a peripheral area 792 to which a cap 790 is attached. It may be preferred that the cap 790 and the backing 760 are formed of materials and sealed together by adhesives, thermal bonds, etc. such that the substrate 720 and microneedles 730 are enclosed within a hermetic, moisture-impermeable package used to transport and store the device 710 before use. In such an embodiment, the cap 790 would be removed to expose the microneedles 730 before use. Although the cap 790 is depicted as having a formed shape, it will be understood that it could be formed of flexible, unshaped materials, (e.g., laminates, etc.).
Also seen in FIG. 14, is a ring of sealing adhesive 748 on the outer surface of the cover 740. The ring of sealing adhesive 748 preferably extends about the periphery of the area occupied by the microneedles 730 and provides sealing and/or attachment functions when the microneedles 730 are inserted into a delivery site as discussed above in connection with FIG. 13 and sealing adhesive 648 depicted therein.
FIG. 15 depicts yet another microneedle device 810 according to the present invention. The device includes microneedles 830 that are preferably segregated in one area of the device 810. A sensor element array 870 is located outside of the area occupied by the microneedles 830 and includes a number of sensor elements 870a, 870b and 870c, all of which may be used to detect the same or different properties or compositions of fluids passing through the capillary volume. In this embodiment, the capillary volume extends over the device such that fluids transmitted into the capillary volume by the microneedles travels across the device 810 into the area occupied by the sensor elements 870. The sensor elements 870 may, for example, be provided in the form of coatings, rather tan separate articles as depicted above.
A ring of sealing adhesive 848 is also depicted in connection with device 810. This ring of sealing adhesive 848 may, for example, be located on a backing that extends beyond the periphery of the substrate on which the microneedles 830 are located (as seen in, e.g., FIG. 14). A cap or liner may then be attached to the adhesive 848 (see, e.g., cap 790 in FIG. 14) to protect it during transport of the device. If a cap is used, it may form a portion of a package in which the device 810 is delivered. Upon removal of the cap or liner, the sealing adhesive 848 is exposed and can be used to attach and/or seal the device 810 to the delivery site.
FIG. 16 depicts one method of providing a cover pierced by microneedles in connection with the manufacturing of microneedle devices according to the present invention. The piercing of the cover 940 by the microneedles 930 may be accomplished by any suitable technique or techniques. It may, however, be preferred that piercing of the cover 940 by the microneedles 930 be accomplished by simultaneous delivery of force and ultrasonic energy. Turning to FIG. 16, the substrate 920 with microneedles 930 may be forced against the cover 940 by an ultrasonic horn 990. It may be preferred that the cover and substrate 920 rest on a resilient material 992 (e.g., silicone rubber having a durometer hardness of approximately 18 on the Shore D scale). As the substrate 920 is forced towards the resilient material 992, ultrasonic energy may assist the microneedles in piercing the cover 940 in a manner that results in the formation of the desired capillary volume as described above.
It is envisioned that other methods of accomplishing piercing of the cover by the microneedles may also be used. For example, it may be desirable to provide heat during the piercing process (alone or in connection with ultrasonic energy). In other instances, it may be sufficient to provide force alone, in some instances an impact force of relatively short duration may be preferred. Furthermore, if ultrasonic energy is used, it may be applied through the cover 940 rather than through the substrate 920 as depicted in FIG. 16.
The microneedles, standoff structure (if any), and conduit structure (if any) may preferably be manufactured integrally with the substrate. In other words, the various features may preferably formed as a one piece, completely integral unit. Alternatively, the microneedles, standoff structures, and/or conduit structures may be provided separately from the substrate.
The microneedle substrates may be manufactured from a variety of materials. Material selection may be based on a variety of factors including the ability of the material to accurately reproduce the desired pattern; the strength and toughness of the material when formed into the microneedles; the compatibility of the material with, for example, human or animal skin; the compatibility of the materials with any fluids to be delivered or removed by the channels formed in the microneedles, etc. For example, it may be preferred that the microneedle arrays of the present invention be manufactured of one or more metals. Regardless of the materials used for the microneedle arrays of the present invention, it may be preferred that the surfaces of the microneedle array that are likely to come into contact with fluids during use have certain wettability characteristics. It may be preferred that these surfaces are hydrophilic, e.g., exhibit a static contact angle for water of less than 90 degrees (possibly less than about 40 degrees), so that the fluid can be spontaneously wicked via capillary pressure. The hydrophilic nature of the surfaces may be provided by selection of materials used to manufacture the entire microneedle array, surface treatments of the entire array or only those portions likely to come into contact with fluids, coatings on the entire array or only those portions likely to come into contact with fluids, etc. Microneedles in the microneedle arrays of the present invention can be solid or porous. As used herein, the term "porous" (and variations thereof) means having that the microneedles include pores or voids through at least a portion of the structure, wherein those pores or voids are sufficiently large and interconnected to permit at least fluid passage. Some suitable processes for forming microneedles of the present invention are described in connection with U.S. Patent Application Serial Number 09/947,195, filed on September 5, 2001 and entitled MICRONEEDLE ARRAYS AND METHODS OF MANUFACTURING THE SAME (Attorney Docket No. 55836US002).
The microneedle devices of the invention may be used in a variety of different manners. One manner of using microneedle devices of the present invention is in methods involving the penetration of skin to deliver medicaments or other substances and/or extract blood or tissue. As discussed above, it may be desired that the height of the microneedles in the microneedle devices be sufficient to penetrate the stratum corneum.
All patents, patent applications, and publications cited herein are each incorporated herein by reference in their entirety, as if individually incorporated by reference. Various modifications and alterations of this invention will become apparent to those skilled in the art without departing from the scope of this invention, and it should'be understood that this invention is not to be unduly limited to the illustrative embodiments set forth herein.

Claims

CLAIMS:
1. A microneedle device comprising: a substrate comprising a first major surface; at least one microneedle projecting from the first major surface of the substrate, the at least one microneedle comprising a base proximate the first major surface of the substrate and a tip distal from the base; a cover comprising a first side facing the first major surface of the substrate and a second side facing away from the substrate, wherein the at least one microneedle penetrates through the first side and the second side of the cover; and a capillary volume located between the first major surface of the substrate and the first side of the cover; wherein the capillary volume contacts at least a portion of the base of the at least one microneedle.
2. A device according to claim 1, wherein the capillary volume comprises conduit structures formed by the substrate.
3. A device according to claim 1, further comprising standoff structure located within the capillary volume, the standoff structure at least partially defining the capillary volume.
4. A device according to claim 3, wherein the standoff structure defines directional channels extending in at least one selected direction.
5. A device according to claim 1, further comprising standoff structure located within the capillary volume, the standoff structure at least partially defining the capillary volume, wherein the standoff structure protrudes from the first major surface of the substrate.
6. A device according to claim 1, further comprising standoff structure located within the capillary volume, the standoff structure at least partially defining the capillary volume, wherein the standoff structure comprises a porous layer with the capillary volume being substantially located within the porous structure.
7. A device according to claim 1, further comprising a hydrophilic surface within the capillary volume.
8. A device according to claim 1, further comprising a channel formed in an outer surface of the at least one microneedle, the channel extending from the base towards the tip of the at least one microneedle.
9. A device according to claim 1, further comprising sealing adhesive on the second side of the cover.
10. A device according to claim 1, wherein the substrate comprises a second major surface facing a housing that is attached to the substrate, wherein a reservoir volume is located between the housing and the substrate, and further wherein the substrate comprises at least one void formed through the first and second major surfaces of the substrate.
11. A microneedle device comprising: a substrate comprising a first major surface and a second major surface; at least one microneedle projecting from the first major surface of the substrate, the at least one microneedle comprising a base proximate the first major surface of the substrate and a tip distal from the base; a cover comprising a first side facing the first major surface of the substrate and a second side facing away from the substrate, wherein the at least one microneedle penetrates through the first side and the second side of the cover; a capillary volume located between the first major surface of the substrate and the first side of the cover; wherein the capillary volume contacts at least a portion of the base of the at least one microneedle; a backing proximate the second major surface of the substrate, wherein the backing extends past a periphery of the substrate; and a cap attached to the backing around the periphery of the substrate, wherein the first major surface of the substrate faces the cap, and wherein the substrate and the at least one microneedle are enclosed between the backing and the cap.
12. A device according to claim 11, wherein the cap is adhesively attached to the backing outside of the periphery of the substrate; wherein the cap is thermally bonded to the backing outside of the periphery of the substrate; or wherein the backing and the cap comprise a moisture-impermeable package enclosing the substrate and the at least one microneedle.
13. A device according to any of the preceding claims, wherein the at least one microneedle comprises a plurality of microneedles.
14. A device according to any of the preceding claims, wherein the cover comprises a liquid impermeable film.
15. A device according to any of the preceding claims, further comprising a sensor element in fluid communication with the capillary volume.
16. A device according to claim 15, further comprising an electrically conductive pattern, wherein a portion of the electrically conductive pattern is in contact with the sensor element.
17. A device according to any of the preceding claims, further comprising a glucose test element in fluid communication with the capillary volume, wherein the device further comprises an electrically conductive pattern comprising an anode and a cathode in contact with the glucose test element.
18. A method of manufacturing a microneedle device comprising: providing a substrate comprising a first major surface and at least one microneedle projecting from the first major surface of the substrate, the at least one microneedle comprising a base proximate the first major surface of the substrate and a tip distal from the base; providing a cover comprising a first side facing the first major surface of the substrate; forcing the tip of the at least one microneedle through the cover; and forming a capillary volume located between the first major surface of the substrate and the first side of the cover; wherein the capillary volume contacts at least a portion of the base of the at least one microneedle.
19. A method according to claim 18, wherein the at least one microneedle comprises a plurality of microneedles, and wherein tips on the plurality of microneedles are forced through the cover.
20. A method according to claim 18, further comprising applying ultrasonic energy to the substrate while forcing the tip of the at least one microneedle through the cover film.
21. A method according to claim 18, further comprising providing a porous layer within the capillary volume, wherein the capillary volume is substantially located within the porous structure.
22. A method according to claim 18, further comprising providing a hydrophilic surface within the capillary volume.
23. A method according to claim 18, further comprising providing a sensor element in fluid communication with the capillary volume.
24. A method according to claim 23, further comprising providing an electrically conductive pattern, wherein a portion of the electrically conductive pattern is in contact with the sensor element.
25. A method according to claim 18, further comprising providing a glucose test element in fluid communication with the capillary volume, wherein the method further comprises providing an electrically conductive pattern comprising an anode and a cathode in contact with the glucose test element.
26. A method according to claim 18, further comprising enclosing the substrate and the at least one microneedle by: providing a backing proximate the second major surface of the substrate, wherein the backing extends past a periphery of the substrate; and attaching a cap to the backing around the periphery of the substrate, wherein the first major surface of the substrate faces the cap.
PCT/US2002/037920 2002-01-15 2002-11-26 Microneedle devices and methods of manufacture WO2003059431A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IL16255402A IL162554A0 (en) 2002-01-15 2002-11-26 Microneedle devices and methods of manufacture
JP2003559591A JP4382492B2 (en) 2002-01-15 2002-11-26 Microneedle device and manufacturing method
DE60224842T DE60224842T2 (en) 2002-01-15 2002-11-26 MICRONADEL DEVICES AND METHOD OF MANUFACTURE
EP02794032A EP1465698B1 (en) 2002-01-15 2002-11-26 Microneedle devices and methods of manufacture
AU2002359490A AU2002359490A1 (en) 2002-01-15 2002-11-26 Microneedle devices and methods of manufacture

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/051,745 2002-01-15
US10/051,745 US6908453B2 (en) 2002-01-15 2002-01-15 Microneedle devices and methods of manufacture

Publications (1)

Publication Number Publication Date
WO2003059431A1 true WO2003059431A1 (en) 2003-07-24

Family

ID=21973131

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/037920 WO2003059431A1 (en) 2002-01-15 2002-11-26 Microneedle devices and methods of manufacture

Country Status (8)

Country Link
US (2) US6908453B2 (en)
EP (1) EP1465698B1 (en)
JP (1) JP4382492B2 (en)
AT (1) ATE384549T1 (en)
AU (1) AU2002359490A1 (en)
DE (1) DE60224842T2 (en)
IL (1) IL162554A0 (en)
WO (1) WO2003059431A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006023684A2 (en) * 2004-08-19 2006-03-02 Alza Coporation Microprojection array patch for transdermal delivery of vascular endothelial growth factors
WO2006060106A1 (en) * 2004-12-02 2006-06-08 Hewlett-Packard Development Company L.P. Transdermal drug delivery device
WO2006062848A1 (en) * 2004-12-10 2006-06-15 3M Innovative Properties Company Medical device
JPWO2005058162A1 (en) * 2003-12-19 2007-07-12 株式会社ライトニックス Medical needle and medical device
JP2008534151A (en) * 2005-03-28 2008-08-28 アルザ コーポレイション Microprojection and method with capillary action control features
US8192787B2 (en) 2004-08-16 2012-06-05 Innoture Limited Method of producing a microneedle or microimplant
US8636696B2 (en) 2011-06-10 2014-01-28 Kimberly-Clark Worldwide, Inc. Transdermal device containing microneedles
JP2016508601A (en) * 2013-01-29 2016-03-22 ヒューレット−パッカード デベロップメント カンパニー エル.ピー.Hewlett‐Packard Development Company, L.P. Apparatus having surface-sensitized spectroscopy elements on the outer surface
JP2016212117A (en) * 2016-08-09 2016-12-15 ヒューレット−パッカード デベロップメント カンパニー エル.ピー.Hewlett‐Packard Development Company, L.P. Apparatus having surface-enhanced spectroscopy element on exterior surface
US9550053B2 (en) 2011-10-27 2017-01-24 Kimberly-Clark Worldwide, Inc. Transdermal delivery of high viscosity bioactive agents
US9962536B2 (en) 2014-04-30 2018-05-08 Kimberly-Clark Worldwide, Inc. Draped microneedle array
US10245421B2 (en) 2010-04-28 2019-04-02 Sorrento Therapeutics, Inc. Nanopatterned medical device with enhanced cellular interaction
US10307578B2 (en) 2005-06-27 2019-06-04 3M Innovative Properties Company Microneedle cartridge assembly and method of applying
US10773065B2 (en) 2011-10-27 2020-09-15 Sorrento Therapeutics, Inc. Increased bioavailability of transdermally delivered agents

Families Citing this family (206)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6908453B2 (en) * 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
CN102872526A (en) 2002-07-19 2013-01-16 3M创新有限公司 Microneedle devices and microneedle delivery apparatus
US7415299B2 (en) * 2003-04-18 2008-08-19 The Regents Of The University Of California Monitoring method and/or apparatus
JP2007503268A (en) * 2003-08-25 2007-02-22 スリーエム イノベイティブ プロパティズ カンパニー Delivery of immune response modifying compounds
CN1842355A (en) * 2003-08-26 2006-10-04 阿尔扎公司 Device and method for intradermal cell implantation
US7378451B2 (en) * 2003-10-17 2008-05-27 3M Innovative Properties Co Surfactant composition having stable hydrophilic character
WO2005044364A1 (en) * 2003-11-10 2005-05-19 Agency For Science, Technology And Research Microneedles and microneedle fabrication
US7753888B2 (en) * 2003-11-21 2010-07-13 The Regents Of The University Of California Method and/or apparatus for puncturing a surface for extraction, in situ analysis, and/or substance delivery using microneedles
WO2005065765A1 (en) * 2003-12-29 2005-07-21 3M Innovative Properties Company Medical devices and kits including same
US7150726B2 (en) * 2004-01-23 2006-12-19 Norfolk Medical Device for subcutaneous infusion of fluids
GB0402131D0 (en) 2004-01-30 2004-03-03 Isis Innovation Delivery method
US8551391B2 (en) * 2004-02-17 2013-10-08 Avery Dennison Corporation Method of making microneedles
JP2007523771A (en) * 2004-02-23 2007-08-23 スリーエム イノベイティブ プロパティズ カンパニー Microneedle array molding method
CN100540086C (en) * 2004-03-12 2009-09-16 新加坡科技研究局 Be used for making the method and the mould of side-ported microneedles
ES2574802T3 (en) * 2004-04-12 2016-06-22 Allergan, Inc. Multi-site injection system
EP1773444B1 (en) * 2004-06-10 2017-09-20 3M Innovative Properties Company Patch application device and kit
US7560036B2 (en) * 2004-08-05 2009-07-14 Apogee Technology, Inc. System and method for drug delivery and microfluidic applications using microneedles
WO2006016364A2 (en) * 2004-08-10 2006-02-16 Hellman De Picciotto, Tania Drug delivery devices
JPWO2006016647A1 (en) * 2004-08-12 2008-05-01 久光製薬株式会社 Transdermal drug administration device with microneedle
AU2005306429B2 (en) 2004-11-18 2011-04-14 3M Innovative Properties Company Microneedle array applicator and retainer
CN101060883B (en) 2004-11-18 2010-06-23 3M创新有限公司 Low-profile microneedle array applicator
WO2006055844A2 (en) 2004-11-18 2006-05-26 3M Innovative Properties Company Method of contact coating a microneedle array
AU2005306426B2 (en) * 2004-11-18 2011-04-28 3M Innovative Properties Company Masking method for coating a microneedle array
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
CA2589733C (en) 2004-12-07 2014-02-11 3M Innovative Properties Company Method of molding a microneedle
JP4793806B2 (en) * 2005-03-22 2011-10-12 Tti・エルビュー株式会社 Iontophoresis device
EP1869414A4 (en) * 2005-03-29 2010-07-28 Arkal Medical Inc Devices, systems, methods and tools for continuous glucose monitoring
JP5301985B2 (en) 2005-04-07 2013-09-25 スリーエム イノベイティブ プロパティズ カンパニー System and method for tool feedback sensing
US20070270738A1 (en) * 2005-04-25 2007-11-22 Wu Jeffrey M Method of treating ACNE with stratum corneum piercing patch
US7442029B2 (en) 2005-05-16 2008-10-28 Asml Netherlands B.V. Imprint lithography
WO2007002523A2 (en) * 2005-06-24 2007-01-04 3M Innovative Properties Company Collapsible patch with microneedle array
EP2474338B1 (en) * 2005-06-27 2013-07-24 3M Innovative Properties Company Microneedle array applicator device
US20070004989A1 (en) * 2005-06-29 2007-01-04 Parvinder Dhillon Device for transdermal sampling
CA2619665A1 (en) 2005-09-15 2007-03-22 Tti Ellebeau, Inc. Rod type iontophoresis device
US20070185432A1 (en) * 2005-09-19 2007-08-09 Transport Pharmaceuticals, Inc. Electrokinetic system and method for delivering methotrexate
US20070066934A1 (en) * 2005-09-19 2007-03-22 Transport Pharmaceuticals, Inc. Electrokinetic delivery system and methods therefor
WO2007038028A1 (en) * 2005-09-28 2007-04-05 Tti Ellebeau, Inc. Iontophoresis apparatus and method to deliver active agents to biological interfaces
US20070093789A1 (en) * 2005-09-30 2007-04-26 Transcutaneous Technologies Inc. Iontophoresis apparatus and method for delivery of angiogenic factors to enhance healing of injured tissue
WO2007041323A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoretic delivery of vesicle-encapsulated active agents
JP2009509657A (en) * 2005-09-30 2009-03-12 Tti・エルビュー株式会社 Iontophoresis device and method for delivery of active agents to biological interfaces
EP1948139A4 (en) * 2005-11-18 2012-04-04 3M Innovative Properties Co Coatable compositions, coatings derived therefrom and microarrays having such coatings
US20080262416A1 (en) * 2005-11-18 2008-10-23 Duan Daniel C Microneedle Arrays and Methods of Preparing Same
EP1962942A1 (en) * 2005-12-21 2008-09-03 3M Innovative Properties Company Microneedle devices
WO2007079193A2 (en) * 2005-12-30 2007-07-12 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
US9339641B2 (en) 2006-01-17 2016-05-17 Emkinetics, Inc. Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US9610459B2 (en) 2009-07-24 2017-04-04 Emkinetics, Inc. Cooling systems and methods for conductive coils
JPWO2007091608A1 (en) * 2006-02-10 2009-07-02 久光製薬株式会社 Transdermal drug administration device with microneedle
EP1820441A1 (en) * 2006-02-16 2007-08-22 Roche Diagnostics GmbH Microneedle arrays with attenuated total reflection (ATR) sensor
US7699819B2 (en) 2006-02-21 2010-04-20 The Hong Kong University Of Science And Technology Molecular sieve and zeolite microneedles and preparation thereof
US20080154107A1 (en) * 2006-12-20 2008-06-26 Jina Arvind N Device, systems, methods and tools for continuous glucose monitoring
US20100049021A1 (en) * 2006-03-28 2010-02-25 Jina Arvind N Devices, systems, methods and tools for continuous analyte monitoring
US20090131778A1 (en) * 2006-03-28 2009-05-21 Jina Arvind N Devices, systems, methods and tools for continuous glucose monitoring
US20080004564A1 (en) * 2006-03-30 2008-01-03 Transcutaneous Technologies Inc. Controlled release membrane and methods of use
WO2007124411A1 (en) * 2006-04-20 2007-11-01 3M Innovative Properties Company Device for applying a microneedle array
DE102006028782A1 (en) * 2006-06-23 2007-12-27 Robert Bosch Gmbh Micro needles storing and transporting device for use in e.g. biochemical area, has active substance-permeable carrier running through reservoir and sub-dividing it into reservoir area with micro needles and another area without needles
US8250729B2 (en) * 2006-07-12 2012-08-28 University Of Utah Research Foundation 3D fabrication of needle tip geometry and knife blade
JP2009545368A (en) * 2006-08-01 2009-12-24 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ Ultrasonic enhanced micro needle
US20080058726A1 (en) * 2006-08-30 2008-03-06 Arvind Jina Methods and Apparatus Incorporating a Surface Penetration Device
ES2380226T3 (en) * 2006-09-04 2012-05-09 F. Hoffmann-La Roche Ag Packaging for hydrophilic medical instruments
US20080097352A1 (en) * 2006-09-12 2008-04-24 Beck Patricia A Methods of fabricating microneedles with bio-sensory functionality
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
TR201807756T4 (en) 2006-09-26 2018-06-21 Infectious Disease Res Inst Vaccine composition containing synthetic adjuvant.
JP4954656B2 (en) * 2006-09-28 2012-06-20 凸版印刷株式会社 Acicular body and method for producing acicular body
US11224742B2 (en) 2006-10-02 2022-01-18 Emkinetics, Inc. Methods and devices for performing electrical stimulation to treat various conditions
US10786669B2 (en) 2006-10-02 2020-09-29 Emkinetics, Inc. Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US9005102B2 (en) 2006-10-02 2015-04-14 Emkinetics, Inc. Method and apparatus for electrical stimulation therapy
AU2007303223C1 (en) 2006-10-02 2013-01-10 Emkinetics, Inc. Method and apparatus for magnetic induction therapy
WO2008062832A1 (en) * 2006-11-22 2008-05-29 Toppan Printing Co., Ltd. Microneedle array and process for production thereof
JP5383497B2 (en) 2006-12-01 2014-01-08 Tti・エルビュー株式会社 System and device for powering and / or controlling a device, for example a transdermal delivery device
US20080234562A1 (en) * 2007-03-19 2008-09-25 Jina Arvind N Continuous analyte monitor with multi-point self-calibration
JP5297595B2 (en) * 2007-03-20 2013-09-25 凸版印刷株式会社 Needle-like body and method for producing needle-like body
US8439861B2 (en) * 2007-04-24 2013-05-14 Velcro Industries B.V. Skin penetrating touch fasteners
TW200841866A (en) * 2007-04-25 2008-11-01 Micro Base Technology Corp Cosmetic or medical patch structure
US20080312518A1 (en) * 2007-06-14 2008-12-18 Arkal Medical, Inc On-demand analyte monitor and method of use
US20090053673A1 (en) * 2007-08-23 2009-02-26 Zimmer, Inc. Method for localized treatment of periodontal tissue
EP2205169B1 (en) * 2007-09-28 2016-11-16 The Queen's University of Belfast Delivery device and method
US20090099427A1 (en) * 2007-10-12 2009-04-16 Arkal Medical, Inc. Microneedle array with diverse needle configurations
EP2231257A4 (en) 2007-12-24 2013-11-06 Univ Queensland Coating method
EP2247527A4 (en) * 2008-02-07 2014-10-29 Univ Queensland Patch production
US8398397B2 (en) * 2008-03-12 2013-03-19 Ultradent Products, Inc. Dental intraligamentary injection needles and related methods of manufacture
US20090259176A1 (en) * 2008-04-09 2009-10-15 Los Gatos Research, Inc. Transdermal patch system
US8012329B2 (en) 2008-05-09 2011-09-06 3M Innovative Properties Company Dimensional control in electroforms
WO2009140735A1 (en) 2008-05-23 2009-11-26 The University Of Queensland Analyte detection by microneedle patch with analyte selective reagents.
US20110150946A1 (en) * 2008-08-22 2011-06-23 Al-Ghananeem Abeer M Transdermal Delivery of Apomorphine Using Microneedles
EP2355887B1 (en) 2008-11-18 2017-08-02 3M Innovative Properties Company Hollow microneedle array
BRPI0922629A2 (en) 2008-12-02 2016-01-05 Allergan Inc injection device
JP5563652B2 (en) 2009-03-17 2014-07-30 カーディオスライヴ インコーポレイテッド External defibrillator
US8781576B2 (en) 2009-03-17 2014-07-15 Cardiothrive, Inc. Device and method for reducing patient transthoracic impedance for the purpose of delivering a therapeutic current
KR101033514B1 (en) * 2009-06-02 2011-05-09 (주)마이티시스템 Flexible Patch System with Micro-needle, and Manufacturing Method of the Same
EP2437753B1 (en) 2009-06-05 2016-08-31 Infectious Disease Research Institute Synthetic glucopyranosyl lipid adjuvants and vaccine compositions containing them
US8062568B2 (en) * 2009-08-27 2011-11-22 Korea University Research And Business Foundation Nano pattern writer
US20110319742A1 (en) * 2009-09-08 2011-12-29 SensiVida Medical Technologies, Inc. Spatial imaging methods for biomedical monitoring and systems thereof
US8834423B2 (en) * 2009-10-23 2014-09-16 University of Pittsburgh—of the Commonwealth System of Higher Education Dissolvable microneedle arrays for transdermal delivery to human skin
JP2013508119A (en) 2009-10-26 2013-03-07 エムキネティクス, インコーポレイテッド Method and apparatus for electromagnetic stimulation of nerves, muscles and body tissues
DE102009046581A1 (en) 2009-11-10 2011-05-12 Robert Bosch Gmbh Manufacturing method for a porous microneedle array and corresponding porous microneedle array and corresponding substrate composite
US20110144591A1 (en) * 2009-12-11 2011-06-16 Ross Russell F Transdermal Delivery Device
US20110172638A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including multi-functional cover
GB2478363A (en) * 2010-03-05 2011-09-07 Ndm Technologies Ltd Microneedle patch and method of manufacture
JP5423522B2 (en) * 2010-03-25 2014-02-19 日本電気株式会社 Module and module manufacturing method
AU2011311255B2 (en) 2010-04-28 2015-10-08 Sorrento Therapeutics, Inc. Method for increasing permeability of an epithelial barrier
FR2959599B1 (en) * 2010-04-28 2013-12-20 Commissariat Energie Atomique DEVICE AND METHOD FOR MECHANICAL TEXTURATION OF A SILICON PLATELET FOR CONSTITUTING A PHOTOVOLTAIC CELL, SILICON PLATE OBTAINED
CN102985131B (en) 2010-04-28 2016-06-29 金伯利-克拉克环球有限公司 For delivering the medical treatment device of siRNA
PT2563450T (en) 2010-04-28 2017-08-28 Kimberly Clark Co Device for delivery of rheumatoid arthritis medication
US8588884B2 (en) 2010-05-28 2013-11-19 Emkinetics, Inc. Microneedle electrode
WO2012006677A1 (en) 2010-07-14 2012-01-19 The University Of Queensland Patch applying apparatus
WO2012048285A1 (en) * 2010-10-08 2012-04-12 Lanco Biosciences, Inc. Delivery of bisphosphonates by microinjection systems
WO2012061556A1 (en) 2010-11-03 2012-05-10 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
US8696637B2 (en) 2011-02-28 2014-04-15 Kimberly-Clark Worldwide Transdermal patch containing microneedles
AU2012243039B2 (en) 2011-04-08 2017-07-13 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
JP2014236758A (en) * 2011-09-30 2014-12-18 テルモ株式会社 Sensor
US11179553B2 (en) 2011-10-12 2021-11-23 Vaxxas Pty Limited Delivery device
CN104363892A (en) 2012-02-07 2015-02-18 传染性疾病研究院 Improved adjuvant formulations comprising tlr4 agonists and methods of using the same
US9944019B2 (en) 2012-05-01 2018-04-17 University of Pittsburgh—of the Commonwealth System of Higher Education Tip-loaded microneedle arrays for transdermal insertion
RS57420B1 (en) 2012-05-16 2018-09-28 Immune Design Corp Vaccines for hsv-2
JP5903016B2 (en) * 2012-06-27 2016-04-13 コスメディ製薬株式会社 Protective release sheet for microneedle patch
US20150173991A1 (en) * 2012-07-06 2015-06-25 The General Hospital Corporation Method and apparatus for dermatological treatment
CN103157178B (en) * 2013-02-05 2014-12-31 北京化工大学 Seal type tool capable of accurately controlling microneedle insertion length
US10543127B2 (en) 2013-02-20 2020-01-28 Cytrellis Biosystems, Inc. Methods and devices for skin tightening
ITMI20130586A1 (en) * 2013-04-11 2014-10-12 Azienda Ospedaliero Universitaria P Isana MICROAGUS AND MICROAGHI MATRIX FOR MEDICAL USE, AND PROCESS OF PRODUCTION OF THAT MATRIX
CA2909221A1 (en) 2013-04-18 2014-10-23 Immune Design Corp. Gla monotherapy for use in cancer treatment
US20140350516A1 (en) 2013-05-23 2014-11-27 Allergan, Inc. Mechanical syringe accessory
US20140350518A1 (en) 2013-05-23 2014-11-27 Allergan, Inc. Syringe extrusion accessory
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
JP6533520B2 (en) * 2013-06-13 2019-06-19 マイクロダーミクス インコーポレイテッドMicrodermics Inc. Method of making metal microneedle
US9656094B2 (en) 2013-06-14 2017-05-23 Cardiothrive, Inc. Biphasic or multiphasic pulse generator and method
US10149973B2 (en) 2013-06-14 2018-12-11 Cardiothrive, Inc. Multipart non-uniform patient contact interface and method of use
US9907970B2 (en) 2013-06-14 2018-03-06 Cardiothrive, Inc. Therapeutic system and method using biphasic or multiphasic pulse waveform
US10279189B2 (en) 2013-06-14 2019-05-07 Cardiothrive, Inc. Wearable multiphasic cardioverter defibrillator system and method
US9616243B2 (en) 2013-06-14 2017-04-11 Cardiothrive, Inc. Dynamically adjustable multiphasic defibrillator pulse system and method
US9833630B2 (en) 2013-06-14 2017-12-05 Cardiothrive, Inc. Biphasic or multiphasic pulse waveform and method
KR102349218B1 (en) 2013-08-09 2022-01-10 사이트렐리스 바이오시스템즈, 인크. Methods and apparatuses for skin treatment using non-thermal tissue ablation
KR101511850B1 (en) * 2013-10-10 2015-04-16 (주)엠큐어 Apparatus for skin treatment having Multi-Needle Hub
WO2015095675A1 (en) 2013-12-19 2015-06-25 Cytrellis Biosystems, Inc. Methods and devices for manipulating subdermal fat
US20160030459A1 (en) 2014-01-21 2016-02-04 Immune Design Corp. Compositions and methods for treating allergic conditions
EP3111986B1 (en) * 2014-02-27 2024-03-27 Toppan Printing Co., Ltd. Microneedle unit and microneedle receptacle
WO2015147030A1 (en) * 2014-03-26 2015-10-01 日本写真印刷株式会社 Packaging body for sheet with conical projections and method for manufacturing same
US10029048B2 (en) 2014-05-13 2018-07-24 Allergan, Inc. High force injection devices
US9987427B1 (en) 2014-06-24 2018-06-05 National Technology & Engineering Solutions Of Sandia, Llc Diagnostic/drug delivery “sense-respond” devices, systems, and uses thereof
US10321858B2 (en) 2014-08-18 2019-06-18 Proteadx, Inc. Apparatus and methods for transdermal sensing of analytes in interstitial fluid and associated data transmission systems
US9933387B1 (en) 2014-09-07 2018-04-03 Biolinq, Inc. Miniaturized sub-nanoampere sensitivity low-noise potentiostat system
US10226585B2 (en) 2014-10-01 2019-03-12 Allergan, Inc. Devices for injection and dosing
JP6906885B2 (en) 2014-11-14 2021-07-21 ロレアル Microneedle sheet to reduce wrinkles
KR102670286B1 (en) 2014-11-14 2024-05-30 사이트렐리스 바이오시스템즈, 인크. Devices and methods for ablation of the skin
JP6717207B2 (en) * 2015-01-27 2020-07-01 凸版印刷株式会社 Transdermal administration device
CA2975275C (en) 2015-02-02 2023-08-29 Vaxxas Pty Limited Microprojection array applicator and method
CA2976544A1 (en) 2015-03-10 2016-09-15 Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company Multiple needle injector
US10441768B2 (en) 2015-03-18 2019-10-15 University of Pittsburgh—of the Commonwealth System of Higher Education Bioactive components conjugated to substrates of microneedle arrays
KR102546426B1 (en) * 2015-04-27 2023-06-22 가부시키가이샤 사이세이 Sheet-like small pieces, a sheet for promoting hair growth containing the small pieces, and a whitening and anti-wrinkle agent containing the small pieces
JP6646985B2 (en) * 2015-09-08 2020-02-14 花王株式会社 Manufacturing method of fine projection tool
US11103259B2 (en) 2015-09-18 2021-08-31 Vaxxas Pty Limited Microprojection arrays with microprojections having large surface area profiles
EP3355981A4 (en) 2015-09-28 2019-05-22 Vaxxas Pty Limited Microprojection arrays with enhanced skin penetrating properties and methods thereof
JP6461761B2 (en) * 2015-10-06 2019-01-30 富士フイルム株式会社 Method for producing transdermal absorption sheet
US11684763B2 (en) 2015-10-16 2023-06-27 University of Pittsburgh—of the Commonwealth System of Higher Education Multi-component bio-active drug delivery and controlled release to the skin by microneedle array devices
MY197273A (en) * 2015-12-04 2023-06-08 Ascilion Ab A microneedle and a chip
WO2017120322A1 (en) 2016-01-05 2017-07-13 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Skin microenvironment targeted delivery for promoting immune and other responses
KR20230117470A (en) 2016-03-29 2023-08-08 사이트렐리스 바이오시스템즈, 인크. Devices and methods for cosmetic skin resurfacing
KR102232054B1 (en) 2016-04-08 2021-03-26 알레간 인코포레이티드 Suction and injection device
WO2017191221A1 (en) * 2016-05-04 2017-11-09 Midge Medical Gmbh Body fluid extraction device
US10092207B1 (en) 2016-05-15 2018-10-09 Biolinq, Inc. Tissue-penetrating electrochemical sensor featuring a co-electrodeposited thin film comprised of polymer and bio-recognition element
CN109562057A (en) 2016-05-16 2019-04-02 传染病研究所 Pegylated liposomal and application method
IL314130A (en) 2016-05-16 2024-09-01 Access To Advanced Health Inst Formulation containing tlr agonist and methods of use
BR112018074352B1 (en) 2016-06-01 2021-11-30 Infectious Disease Research Institute NANOALUME PARTICLES CONTAINING A SIZING AGENT
KR102515836B1 (en) 2016-09-21 2023-03-31 사이트렐리스 바이오시스템즈, 인크. Device and method for cosmetic skin resurfacing
WO2018093465A1 (en) 2016-11-21 2018-05-24 Eirion Therapeutics, Inc. Transdermal delivery of large agents
KR20190070335A (en) * 2016-11-23 2019-06-20 유니버시티 메디컬 파마슈티컬스 코퍼레이션 Micro needle delivery system and method
JP6977258B2 (en) * 2016-12-20 2021-12-08 株式会社リコー Hollow structure
EP3338832A1 (en) * 2016-12-23 2018-06-27 Sanofi-Aventis Deutschland GmbH Medicament delivery device
US12109032B1 (en) 2017-03-11 2024-10-08 Biolinq Incorporated Methods for achieving an isolated electrical interface between an anterior surface of a microneedle structure and a posterior surface of a support structure
USD867582S1 (en) 2017-03-24 2019-11-19 Allergan, Inc. Syringe device
EP4306803A3 (en) 2017-03-31 2024-04-10 Vaxxas Pty Limited Device and method for coating surfaces
US11045142B1 (en) 2017-04-29 2021-06-29 Biolinq, Inc. Heterogeneous integration of silicon-fabricated solid microneedle sensors and CMOS circuitry
CA3066915A1 (en) 2017-06-11 2018-12-20 Molecular Express, Inc. Methods and compositions for substance use disorder vaccine formulations and uses thereof
US11175128B2 (en) 2017-06-13 2021-11-16 Vaxxas Pty Limited Quality control of substrate coatings
JP6931222B2 (en) * 2017-07-18 2021-09-01 コスメディ製薬株式会社 Foam support sheet for microneedle array
EP4218893A1 (en) 2017-08-04 2023-08-02 Vaxxas Pty Limited Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (map)
US11766203B2 (en) 2017-09-13 2023-09-26 National Technology & Engineering Solutions Of Sandia, Llc Coaxial microneedle assemblies and methods thereof
TWI667016B (en) * 2017-11-20 2019-08-01 研能科技股份有限公司 Blood sugar detecting and controlling system
US20200315502A1 (en) * 2017-12-21 2020-10-08 Georgia Tech Research Corporation Methods and Systems for Improved Collection of Interstitial Fluid
US10828500B2 (en) 2017-12-22 2020-11-10 Cardiothrive, Inc. External defibrillator
SG10201800072YA (en) * 2018-01-03 2019-08-27 Micropoint Tech Pte Ltd Microneedle Patches Comprising Corticosteroid
US10918839B2 (en) * 2018-03-13 2021-02-16 II Jaro Mayda Balloon catheter
CN111801135B (en) * 2018-03-30 2023-06-27 富士胶片株式会社 Method for manufacturing microneedle array
USD875254S1 (en) 2018-06-08 2020-02-11 Biolinq, Inc. Intradermal biosensor
JP2022500452A (en) 2018-09-13 2022-01-04 エイリオン セラピューティクス, インコーポレイテッド Use of plasminogen activator inhibitor 1 (PAI-1) inhibitor (inhibitor)
EP3849539A1 (en) 2018-09-13 2021-07-21 Eirion Therapeutics, Inc. Plasminogen activator inhibitor 1 (pai-1) inhibitors and uses therefor
US20210338158A1 (en) 2018-10-02 2021-11-04 WearOptimo Pty Ltd Measurement system
WO2020069567A1 (en) 2018-10-02 2020-04-09 WearOptimo Pty Ltd Electrode arrangement
CN113423381A (en) 2018-12-03 2021-09-21 艾里奥治疗公司 Improved delivery of large agents
CA3139983A1 (en) 2019-05-14 2020-11-19 Eirion Therapeutics, Inc. Delaying peak effect and/or extending duration of response
CN111939452A (en) * 2019-05-15 2020-11-17 微邦科技股份有限公司 Microneedle structure and biodegradable microneedle thereof
TWI687247B (en) * 2019-05-15 2020-03-11 微邦科技股份有限公司 Microneedle structure and biodegradable microneedle thereof
EP3772331A1 (en) * 2019-08-08 2021-02-10 PKvitality Body monitoring system comprising a microneedle
CN110711312B (en) * 2019-11-07 2021-07-30 河南大学 Micro-electromechanical system based strong permeation-promoting transdermal drug release micro-system and manufacturing method thereof
CN115379797A (en) 2020-07-29 2022-11-22 比奥林公司 Continuous analyte monitoring system with microneedle array
WO2022118859A1 (en) * 2020-12-01 2022-06-09 三井化学株式会社 Microneedle array, microneedle array assembly, and test chip
US20240050561A1 (en) 2020-12-23 2024-02-15 Access To Advanced Health Institute Solanesol vaccine adjuvants and methods of preparing same
CN112858430B (en) * 2021-01-08 2021-11-26 中山大学 Sensor for detecting plant active small molecules and preparation method
USD988160S1 (en) * 2021-03-16 2023-06-06 Biolinq Incorporated Wearable dermal sensor
EP4153276A4 (en) 2021-05-08 2023-11-08 Biolinq, Inc. Fault detection for microneedle array based continuous analyte monitoring device
CN113499537A (en) * 2021-09-03 2021-10-15 河南佳普医药科技有限公司 Microneedle transdermal delivery device
JP7141625B1 (en) 2021-09-17 2022-09-26 リンテック株式会社 Microneedle patch and microneedle structure
USD996999S1 (en) * 2021-11-16 2023-08-29 Biolinq Incorporated Wearable sensor
USD1013544S1 (en) * 2022-04-29 2024-02-06 Biolinq Incorporated Wearable sensor
USD1012744S1 (en) * 2022-05-16 2024-01-30 Biolinq Incorporated Wearable sensor with illuminated display
WO2024129424A1 (en) * 2022-12-16 2024-06-20 Kindeva Drug Delivery L.P. Drug delivery device
USD1035004S1 (en) 2023-02-28 2024-07-09 Biolinq Incorporated Wearable sensor

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620095A (en) 1993-06-11 1997-04-15 Minnesota Mining And Manufacturing Company Orthopedic casting material and hermetic package
WO1998000193A1 (en) * 1996-07-03 1998-01-08 Altea Technologies, Inc. Multiple mechanical microporation of skin or mucosa
WO1998028037A1 (en) * 1996-12-20 1998-07-02 Alza Corporation Device and method for enhancing transdermal agent flux
US6099682A (en) 1998-02-09 2000-08-08 3M Innovative Properties Company Corporation Of Delaware Cold seal package and method for making the same
WO2001036037A2 (en) * 1999-11-15 2001-05-25 Velcro Industries B.V. Skin attachment member
WO2001066065A2 (en) * 2000-03-09 2001-09-13 Nanopass Ltd. Systems and methods for fluid transport through dermal barriers
WO2001093930A1 (en) * 2000-06-02 2001-12-13 The University Of Utah Research Foundation Active needle devices with integrated functionality

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3123212A (en) * 1964-03-03 Multiple disposable intracutaneous injector package
NL113697C (en) * 1954-04-27
US3034507A (en) * 1960-05-10 1962-05-15 American Cyanamid Co Intracutaneous injection device
US3074403A (en) * 1960-05-17 1963-01-22 American Cyanamid Co Intracutaneous injector with capillary gap
US3136314A (en) * 1960-08-01 1964-06-09 Kravitz Harvey Vaccinating devices
US3246647A (en) * 1962-07-23 1966-04-19 American Cyanamid Co Disposable intracutaneous injector
US3466131A (en) * 1967-09-07 1969-09-09 Becton Dickinson Co Dispensing applicator package
US3675766A (en) * 1970-02-04 1972-07-11 Sol Roy Rosenthal Multiple puncture injector device
US3688764A (en) * 1970-08-20 1972-09-05 Bard Hamilton Co Inc Intracutaneous injection system
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
US3678150A (en) * 1971-07-27 1972-07-18 American Cyanamid Co Process for improving the stability of ppd, qt and histoplasmin on tine applicators
DE2250293A1 (en) * 1972-10-13 1974-04-25 Bayern Freistaat Inoculation stamps for cutaneous smallpox inoculation using dry vaccine
OA05448A (en) * 1975-10-16 1981-03-31 Manufrance Manufacture Francai Multi-penetrating vaccine device.
US4473083A (en) * 1981-12-14 1984-09-25 Maganias Nicholas H Device and method for allergy testing
US4921475A (en) * 1983-08-18 1990-05-01 Drug Delivery Systems Inc. Transdermal drug patch with microtubes
GB2221394B (en) 1988-08-05 1992-03-04 Eilert Eilertsen An injection device
US6090790A (en) * 1989-12-14 2000-07-18 Eriksson; Elof Gene delivery by microneedle injection
US5402798A (en) * 1991-07-18 1995-04-04 Swierczek; Remi Disposable skin perforator and blood testing device
US5342737A (en) * 1992-04-27 1994-08-30 The United States Of America As Represented By The Secretary Of The Navy High aspect ratio metal microstructures and method for preparing the same
AU675440B2 (en) * 1992-06-18 1997-02-06 United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Recombinant (pseudomonas) exotoxin with increased activity
JP3211525B2 (en) 1993-04-22 2001-09-25 オムロン株式会社 Thin material mesh, its manufacturing method and its manufacturing apparatus
US5611806A (en) * 1994-05-23 1997-03-18 Samsung Electro-Mechanics Co., Ltd. Skin perforating device for transdermal medication
JP4180654B2 (en) 1995-04-26 2008-11-12 スリーエム カンパニー Method and apparatus for step-and-repeat exposure
AU5740496A (en) * 1995-05-22 1996-12-11 General Hospital Corporation, The Micromechanical device and method for enhancing delivery of compounds through the skin
WO1996037256A1 (en) * 1995-05-22 1996-11-28 Silicon Microdevices, Inc. Micromechanical patch for enhancing the delivery of compounds through the skin
JP2725637B2 (en) * 1995-05-31 1998-03-11 日本電気株式会社 Electronic circuit device and method of manufacturing the same
DE19525607A1 (en) 1995-07-14 1997-01-16 Boehringer Ingelheim Kg Transcorneal drug delivery system
US5658515A (en) * 1995-09-25 1997-08-19 Lee; Abraham P. Polymer micromold and fabrication process
US5657516A (en) * 1995-10-12 1997-08-19 Minnesota Mining And Manufacturing Company Dual structured fastener elements
ZA975326B (en) * 1996-06-18 1998-01-14 Alza Corp Device and method for enhancing transdermal flux of agents being delivered or sampled.
US6797276B1 (en) * 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
US6605332B2 (en) * 1997-07-29 2003-08-12 3M Innovative Properties Company Unitary polymer substrate having napped surface of frayed end microfibers
US6918901B1 (en) * 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
CA2313698C (en) * 1997-12-11 2008-04-15 Alza Corporation Device for enhancing transdermal agent flux
KR100572539B1 (en) * 1997-12-11 2006-04-24 알자 코포레이션 Device for enhancing transdermal agent flux
EP1086214B1 (en) * 1998-06-10 2009-11-25 Georgia Tech Research Corporation Microneedle devices and methods of their manufacture
US6503231B1 (en) * 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
GB9815819D0 (en) * 1998-07-22 1998-09-16 Secr Defence Transferring materials into cells and a microneedle array
GB9815820D0 (en) 1998-07-22 1998-09-16 Secr Defence Improvements relating to micro-machining
WO2000012173A1 (en) * 1998-08-31 2000-03-09 Johnson & Johnson Consumer Companies, Inc. Electrotransport device comprising blades
AU2189400A (en) * 1998-12-18 2000-07-03 Minimed, Inc. Insertion sets with micro-piercing members for use with medical devices and methods of using the same
DE60007290T2 (en) * 1999-01-28 2004-09-23 Cyto Pulse Sciences, Inc. INTRODUCTION OF MACROMOLECULES IN CELLS
US6713291B2 (en) * 1999-01-28 2004-03-30 Alan D. King Electrodes coated with treating agent and uses thereof
US6611707B1 (en) * 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
EP1187653B1 (en) 1999-06-04 2010-03-31 Georgia Tech Research Corporation Devices for enhanced microneedle penetration of biological barriers
US6743211B1 (en) * 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6256533B1 (en) * 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US6312612B1 (en) 1999-06-09 2001-11-06 The Procter & Gamble Company Apparatus and method for manufacturing an intracutaneous microneedle array
US6379324B1 (en) * 1999-06-09 2002-04-30 The Procter & Gamble Company Intracutaneous microneedle array apparatus
US6623457B1 (en) 1999-09-22 2003-09-23 Becton, Dickinson And Company Method and apparatus for the transdermal administration of a substance
US6835184B1 (en) 1999-09-24 2004-12-28 Becton, Dickinson And Company Method and device for abrading skin
US6331266B1 (en) * 1999-09-29 2001-12-18 Becton Dickinson And Company Process of making a molded device
US20020095134A1 (en) * 1999-10-14 2002-07-18 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
US6551849B1 (en) * 1999-11-02 2003-04-22 Christopher J. Kenney Method for fabricating arrays of micro-needles
US6558361B1 (en) * 2000-03-09 2003-05-06 Nanopass Ltd. Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems
US6595947B1 (en) * 2000-05-22 2003-07-22 Becton, Dickinson And Company Topical delivery of vaccines
US6565532B1 (en) * 2000-07-12 2003-05-20 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
US6537242B1 (en) * 2000-06-06 2003-03-25 Becton, Dickinson And Company Method and apparatus for enhancing penetration of a member for the intradermal sampling or administration of a substance
US7141034B2 (en) * 2000-06-08 2006-11-28 Altea Therapeutics Corporation Transdermal drug delivery device, method of making same and method of using same
US6589202B1 (en) * 2000-06-29 2003-07-08 Becton Dickinson And Company Method and apparatus for transdermally sampling or administering a substance to a patient
US6440096B1 (en) * 2000-07-14 2002-08-27 Becton, Dickinson And Co. Microdevice and method of manufacturing a microdevice
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US6749575B2 (en) * 2001-08-20 2004-06-15 Alza Corporation Method for transdermal nucleic acid sampling
US6533949B1 (en) * 2000-08-28 2003-03-18 Nanopass Ltd. Microneedle structure and production method therefor
AU8877401A (en) * 2000-09-08 2002-03-22 Alza Corp Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure
HUP0303576A2 (en) * 2000-10-13 2004-01-28 Alza Corp Microprotrusion member retainer for impact applicator
US6821281B2 (en) * 2000-10-16 2004-11-23 The Procter & Gamble Company Microstructures for treating and conditioning skin
HUP0302924A2 (en) * 2000-10-26 2003-12-29 Alza Corp Transdermal drug delivery devices having coated microprotrusions
EP1345646A2 (en) * 2000-12-14 2003-09-24 Georgia Tech Research Corporation Microneedle devices and production thereof
AU2002231207A1 (en) * 2000-12-21 2002-07-01 Biovalve Technologies, Inc. Microneedle array systems
US20020099356A1 (en) * 2001-01-19 2002-07-25 Unger Evan C. Transmembrane transport apparatus and method
US6663820B2 (en) * 2001-03-14 2003-12-16 The Procter & Gamble Company Method of manufacturing microneedle structures using soft lithography and photolithography
US6591124B2 (en) * 2001-05-11 2003-07-08 The Procter & Gamble Company Portable interstitial fluid monitoring system
AU2002312315A1 (en) * 2001-06-08 2002-12-23 The Regents Of The University Of California Microfabricated surgical devices and methods of making the same
US6686299B2 (en) * 2001-06-21 2004-02-03 Carlo D. Montemagno Nanosyringe array and method
US6746590B2 (en) * 2001-09-05 2004-06-08 3M Innovative Properties Company Ultrasonically-enhanced electroplating apparatus and methods
US6881203B2 (en) * 2001-09-05 2005-04-19 3M Innovative Properties Company Microneedle arrays and methods of manufacturing the same
AU2002327675A1 (en) * 2001-09-19 2003-04-01 Biovalve Technologies, Inc. Microneedles, microneedle arrays, and systems and methods relating to same
AU2002337788A1 (en) * 2001-09-28 2003-04-07 Biovalve Technologies, Inc. Microneedle with membrane
US6689100B2 (en) * 2001-10-05 2004-02-10 Becton, Dickinson And Company Microdevice and method of delivering or withdrawing a substance through the skin of an animal
US7429258B2 (en) * 2001-10-26 2008-09-30 Massachusetts Institute Of Technology Microneedle transport device
EP1439870B1 (en) * 2001-10-29 2009-01-14 Becton, Dickinson and Company Device for the delivery of a substance
AU2002360361A1 (en) * 2001-11-09 2003-06-10 Biomicroarrays, Inc. High surface area substrates for microarrays and methods to make same
HUP0402605A2 (en) * 2001-12-20 2005-06-28 Alza Corporation Skin-piercing microprojections having piercing depth control
US6908453B2 (en) * 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
US20040060902A1 (en) * 2002-02-05 2004-04-01 Evans John D. Microprotrusion array and methods of making a microprotrusion
US6780171B2 (en) * 2002-04-02 2004-08-24 Becton, Dickinson And Company Intradermal delivery device
US6899838B2 (en) * 2002-07-12 2005-05-31 Becton, Dickinson And Company Method of forming a mold and molding a micro-device
DK1523355T3 (en) * 2002-07-22 2019-04-23 Becton Dickinson Co PLASTER-LIKE INFUSION DEVICE
ES2617576T3 (en) * 2002-08-29 2017-06-19 Becton, Dickinson And Company Substance administration through a rotating microabrasive system
WO2004033021A1 (en) * 2002-10-07 2004-04-22 Biovalve Technologies, Inc. Microneedle array patch
WO2005000382A2 (en) * 2003-06-04 2005-01-06 Georgia Tech Research Corporation Drilling microneedle device
UY28398A1 (en) * 2003-07-02 2004-11-08 Alza Corp IMMUNIZATION METHOD AND PATCH BY MICROPROJECTION PROVISION
TW200514596A (en) * 2003-08-04 2005-05-01 Alza Corp Method and device for enhancing transdermal agent flux
CA2535138C (en) * 2003-08-12 2013-01-08 Becton, Dickinson And Company Patch-like infusion device
CN1842355A (en) * 2003-08-26 2006-10-04 阿尔扎公司 Device and method for intradermal cell implantation
US8353861B2 (en) * 2003-09-18 2013-01-15 Texmac, Inc. Applicator for applying functional substances into human skin
AU2004285481A1 (en) * 2003-10-24 2005-05-12 Alza Corporation Apparatus and method for enhancing transdermal drug delivery
BRPI0415466A (en) * 2003-10-24 2006-12-19 Alza Corp pretreatment method and system for enhancing transdermal drug delivery
CN1897883A (en) * 2003-10-28 2007-01-17 阿尔扎公司 Delivery of polymer conjugates of therapeutic peptides and proteins via coated microprojections

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620095A (en) 1993-06-11 1997-04-15 Minnesota Mining And Manufacturing Company Orthopedic casting material and hermetic package
WO1998000193A1 (en) * 1996-07-03 1998-01-08 Altea Technologies, Inc. Multiple mechanical microporation of skin or mucosa
WO1998028037A1 (en) * 1996-12-20 1998-07-02 Alza Corporation Device and method for enhancing transdermal agent flux
US6099682A (en) 1998-02-09 2000-08-08 3M Innovative Properties Company Corporation Of Delaware Cold seal package and method for making the same
WO2001036037A2 (en) * 1999-11-15 2001-05-25 Velcro Industries B.V. Skin attachment member
WO2001066065A2 (en) * 2000-03-09 2001-09-13 Nanopass Ltd. Systems and methods for fluid transport through dermal barriers
WO2001093930A1 (en) * 2000-06-02 2001-12-13 The University Of Utah Research Foundation Active needle devices with integrated functionality

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005058162A1 (en) * 2003-12-19 2007-07-12 株式会社ライトニックス Medical needle and medical device
US7361182B2 (en) 2003-12-19 2008-04-22 Lightnix, Inc. Medical lancet
US7740621B2 (en) 2003-12-19 2010-06-22 Lightnix, Inc. Medical needle and medical device
US8192787B2 (en) 2004-08-16 2012-06-05 Innoture Limited Method of producing a microneedle or microimplant
WO2006023684A3 (en) * 2004-08-19 2006-04-13 Alza Coporation Microprojection array patch for transdermal delivery of vascular endothelial growth factors
WO2006023684A2 (en) * 2004-08-19 2006-03-02 Alza Coporation Microprojection array patch for transdermal delivery of vascular endothelial growth factors
WO2006060106A1 (en) * 2004-12-02 2006-06-08 Hewlett-Packard Development Company L.P. Transdermal drug delivery device
WO2006062848A1 (en) * 2004-12-10 2006-06-15 3M Innovative Properties Company Medical device
JP2008534151A (en) * 2005-03-28 2008-08-28 アルザ コーポレイション Microprojection and method with capillary action control features
US10307578B2 (en) 2005-06-27 2019-06-04 3M Innovative Properties Company Microneedle cartridge assembly and method of applying
US12017031B2 (en) 2010-04-28 2024-06-25 Sorrento Therapeutics, Inc. Nanopatterned medical device with enhanced cellular interaction
US11179555B2 (en) 2010-04-28 2021-11-23 Sorrento Therapeutics, Inc. Nanopatterned medical device with enhanced cellular interaction
US10245421B2 (en) 2010-04-28 2019-04-02 Sorrento Therapeutics, Inc. Nanopatterned medical device with enhanced cellular interaction
US8636696B2 (en) 2011-06-10 2014-01-28 Kimberly-Clark Worldwide, Inc. Transdermal device containing microneedles
US10213588B2 (en) 2011-10-27 2019-02-26 Sorrento Therapeutics, Inc. Transdermal delivery of high viscosity bioactive agents
US9550053B2 (en) 2011-10-27 2017-01-24 Kimberly-Clark Worldwide, Inc. Transdermal delivery of high viscosity bioactive agents
US10773065B2 (en) 2011-10-27 2020-09-15 Sorrento Therapeutics, Inc. Increased bioavailability of transdermally delivered agents
US11129975B2 (en) 2011-10-27 2021-09-28 Sorrento Therapeutics, Inc. Transdermal delivery of high viscosity bioactive agents
US9675288B2 (en) 2013-01-29 2017-06-13 Hewlett-Packard Development Company, L.P. Apparatus having surface-enhanced spectroscopy elements on an exterior surface
JP2016508601A (en) * 2013-01-29 2016-03-22 ヒューレット−パッカード デベロップメント カンパニー エル.ピー.Hewlett‐Packard Development Company, L.P. Apparatus having surface-sensitized spectroscopy elements on the outer surface
US9962536B2 (en) 2014-04-30 2018-05-08 Kimberly-Clark Worldwide, Inc. Draped microneedle array
JP2016212117A (en) * 2016-08-09 2016-12-15 ヒューレット−パッカード デベロップメント カンパニー エル.ピー.Hewlett‐Packard Development Company, L.P. Apparatus having surface-enhanced spectroscopy element on exterior surface

Also Published As

Publication number Publication date
JP2005514179A (en) 2005-05-19
EP1465698B1 (en) 2008-01-23
EP1465698A1 (en) 2004-10-13
IL162554A0 (en) 2005-11-20
AU2002359490A1 (en) 2003-07-30
ATE384549T1 (en) 2008-02-15
DE60224842T2 (en) 2009-01-22
JP4382492B2 (en) 2009-12-16
DE60224842D1 (en) 2008-03-13
US6908453B2 (en) 2005-06-21
US20030135161A1 (en) 2003-07-17
US20050187521A1 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
EP1465698B1 (en) Microneedle devices and methods of manufacture
JP4836392B2 (en) Skin permeation enhancing device for extracting or administering a substance and method for manufacturing the device
EP1819393B1 (en) Medical device
JP4668535B2 (en) A device that supplies or withdraws substances through the skin of animals
CN100553710C (en) The apparatus and method of percutaneous transmission or extraction of substance
US7914480B2 (en) Transdermal delivery device
EP1896115B2 (en) Microneedle cartridge assembly
EP1490145A1 (en) Method and device for intradermally delivering a substance
JP2014511243A (en) Transdermal patch with microneedle
AU2002330234A1 (en) Microdevice and method of delivering or withdrawing a substance through the skin of an animal
US9717451B2 (en) Device for withdrawing or administering a substance and method of manufacturing a device
JP7141625B1 (en) Microneedle patch and microneedle structure
JP2008188273A (en) Medicine delivery device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 162554

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2002794032

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2003559591

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2002794032

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2002794032

Country of ref document: EP